Cancer treatment and survivorship statistics, 2025
The number of people living with a history of cancer in the United States continues to rise because of the growth and aging of the population as well as improved survival through advances in early detection and treatment. To assist the public health community serve the needs of these survivors, the...
Gespeichert in:
| Veröffentlicht in: | CA: a cancer journal for clinicians Jg. 75; H. 4; S. 308 - 340 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
United States
Wiley Subscription Services, Inc
01.08.2025
John Wiley and Sons Inc |
| Schlagworte: | |
| ISSN: | 0007-9235, 1542-4863, 1542-4863 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | The number of people living with a history of cancer in the United States continues to rise because of the growth and aging of the population as well as improved survival through advances in early detection and treatment. To assist the public health community serve the needs of these survivors, the American Cancer Society and the National Cancer Institute collaborate triennially to estimate cancer prevalence in the United States using data from the Surveillance, Epidemiology, and End Results cancer registries, the Centers for Disease Control and Prevention's National Center for Health Statistics, and the United States Census Bureau. In addition, cancer treatment patterns are presented from the National Cancer Database along with a brief overview of treatment‐related side effects. As of January 1, 2025, about 18.6 million people were living in the United States with a history of cancer, and this number is projected to exceed 22 million by 2035. The three most prevalent cancers are prostate (3,552,460), melanoma of the skin (816,580), and colorectum (729,550) among males and breast (4,305,570), uterine corpus (945,540), and thyroid (859,890) among females. About one half (51%) of survivors were diagnosed within the past 10 years, and nearly four fifths (79%) were aged 60 years and older. Racial differences in treatment in 2021 were common across disease stage; for example, Black people with stage I‐II lung cancer were less likely to undergo surgery than their White counterparts (47% vs. 52%). Larger disparities exist for rectal cancer, for which 39% of Black people with stage I disease undergo proctectomy or proctocolectomy compared to 64% of their White counterparts. Targeted, multi‐level efforts to expand access to high‐quality care and survivorship resources are vital to reducing disparities and advancing support for all survivors of cancer. |
|---|---|
| AbstractList | The number of people living with a history of cancer in the United States continues to rise because of the growth and aging of the population as well as improved survival through advances in early detection and treatment. To assist the public health community serve the needs of these survivors, the American Cancer Society and the National Cancer Institute collaborate triennially to estimate cancer prevalence in the United States using data from the Surveillance, Epidemiology, and End Results cancer registries, the Centers for Disease Control and Prevention's National Center for Health Statistics, and the United States Census Bureau. In addition, cancer treatment patterns are presented from the National Cancer Database along with a brief overview of treatment-related side effects. As of January 1, 2025, about 18.6 million people were living in the United States with a history of cancer, and this number is projected to exceed 22 million by 2035. The three most prevalent cancers are prostate (3,552,460), melanoma of the skin (816,580), and colorectum (729,550) among males and breast (4,305,570), uterine corpus (945,540), and thyroid (859,890) among females. About one half (51%) of survivors were diagnosed within the past 10 years, and nearly four fifths (79%) were aged 60 years and older. Racial differences in treatment in 2021 were common across disease stage; for example, Black people with stage I-II lung cancer were less likely to undergo surgery than their White counterparts (47% vs. 52%). Larger disparities exist for rectal cancer, for which 39% of Black people with stage I disease undergo proctectomy or proctocolectomy compared to 64% of their White counterparts. Targeted, multi-level efforts to expand access to high-quality care and survivorship resources are vital to reducing disparities and advancing support for all survivors of cancer. The number of people living with a history of cancer in the United States continues to rise because of the growth and aging of the population as well as improved survival through advances in early detection and treatment. To assist the public health community serve the needs of these survivors, the American Cancer Society and the National Cancer Institute collaborate triennially to estimate cancer prevalence in the United States using data from the Surveillance, Epidemiology, and End Results cancer registries, the Centers for Disease Control and Prevention's National Center for Health Statistics, and the United States Census Bureau. In addition, cancer treatment patterns are presented from the National Cancer Database along with a brief overview of treatment-related side effects. As of January 1, 2025, about 18.6 million people were living in the United States with a history of cancer, and this number is projected to exceed 22 million by 2035. The three most prevalent cancers are prostate (3,552,460), melanoma of the skin (816,580), and colorectum (729,550) among males and breast (4,305,570), uterine corpus (945,540), and thyroid (859,890) among females. About one half (51%) of survivors were diagnosed within the past 10 years, and nearly four fifths (79%) were aged 60 years and older. Racial differences in treatment in 2021 were common across disease stage; for example, Black people with stage I-II lung cancer were less likely to undergo surgery than their White counterparts (47% vs. 52%). Larger disparities exist for rectal cancer, for which 39% of Black people with stage I disease undergo proctectomy or proctocolectomy compared to 64% of their White counterparts. Targeted, multi-level efforts to expand access to high-quality care and survivorship resources are vital to reducing disparities and advancing support for all survivors of cancer. The number of people living with a history of cancer in the United States continues to rise because of the growth and aging of the population as well as improved survival through advances in early detection and treatment. To assist the public health community serve the needs of these survivors, the American Cancer Society and the National Cancer Institute collaborate triennially to estimate cancer prevalence in the United States using data from the Surveillance, Epidemiology, and End Results cancer registries, the Centers for Disease Control and Prevention's National Center for Health Statistics, and the United States Census Bureau. In addition, cancer treatment patterns are presented from the National Cancer Database along with a brief overview of treatment-related side effects. As of January 1, 2025, about 18.6 million people were living in the United States with a history of cancer, and this number is projected to exceed 22 million by 2035. The three most prevalent cancers are prostate (3,552,460), melanoma of the skin (816,580), and colorectum (729,550) among males and breast (4,305,570), uterine corpus (945,540), and thyroid (859,890) among females. About one half (51%) of survivors were diagnosed within the past 10 years, and nearly four fifths (79%) were aged 60 years and older. Racial differences in treatment in 2021 were common across disease stage; for example, Black people with stage I-II lung cancer were less likely to undergo surgery than their White counterparts (47% vs. 52%). Larger disparities exist for rectal cancer, for which 39% of Black people with stage I disease undergo proctectomy or proctocolectomy compared to 64% of their White counterparts. Targeted, multi-level efforts to expand access to high-quality care and survivorship resources are vital to reducing disparities and advancing support for all survivors of cancer.The number of people living with a history of cancer in the United States continues to rise because of the growth and aging of the population as well as improved survival through advances in early detection and treatment. To assist the public health community serve the needs of these survivors, the American Cancer Society and the National Cancer Institute collaborate triennially to estimate cancer prevalence in the United States using data from the Surveillance, Epidemiology, and End Results cancer registries, the Centers for Disease Control and Prevention's National Center for Health Statistics, and the United States Census Bureau. In addition, cancer treatment patterns are presented from the National Cancer Database along with a brief overview of treatment-related side effects. As of January 1, 2025, about 18.6 million people were living in the United States with a history of cancer, and this number is projected to exceed 22 million by 2035. The three most prevalent cancers are prostate (3,552,460), melanoma of the skin (816,580), and colorectum (729,550) among males and breast (4,305,570), uterine corpus (945,540), and thyroid (859,890) among females. About one half (51%) of survivors were diagnosed within the past 10 years, and nearly four fifths (79%) were aged 60 years and older. Racial differences in treatment in 2021 were common across disease stage; for example, Black people with stage I-II lung cancer were less likely to undergo surgery than their White counterparts (47% vs. 52%). Larger disparities exist for rectal cancer, for which 39% of Black people with stage I disease undergo proctectomy or proctocolectomy compared to 64% of their White counterparts. Targeted, multi-level efforts to expand access to high-quality care and survivorship resources are vital to reducing disparities and advancing support for all survivors of cancer. |
| Author | Wagle, Nikita Sandeep Jemal, Ahmedin Mariotto, Angela B. Devasia, Theresa P. Islami, Farhad Alteri, Rick Nogueira, Leticia Ganz, Patricia A. Siegel, Rebecca L. Yabroff, K. Robin |
| AuthorAffiliation | 5 Surveillance and Health Equity Science American Cancer Society Atlanta Georgia USA 6 Medical & Health Content American Cancer Society Atlanta Georgia USA 4 Cancer Disparity Research American Cancer Society Atlanta Georgia USA 1 Cancer Surveillance Research American Cancer Society Atlanta Georgia USA 3 Statistical Research and Applications Branch Surveillance Research Program Division of Cancer Control and Population Sciences National Cancer Institute Bethesda Maryland USA 7 Department of Health Policy and Management UCLA Fielding School of Public Health Los Angeles California USA 2 Health Services Research American Cancer Society Atlanta Georgia USA 8 Department of Medicine David Geffen School of Medicine at UCLA Los Angeles California USA |
| AuthorAffiliation_xml | – name: 6 Medical & Health Content American Cancer Society Atlanta Georgia USA – name: 7 Department of Health Policy and Management UCLA Fielding School of Public Health Los Angeles California USA – name: 8 Department of Medicine David Geffen School of Medicine at UCLA Los Angeles California USA – name: 4 Cancer Disparity Research American Cancer Society Atlanta Georgia USA – name: 1 Cancer Surveillance Research American Cancer Society Atlanta Georgia USA – name: 5 Surveillance and Health Equity Science American Cancer Society Atlanta Georgia USA – name: 2 Health Services Research American Cancer Society Atlanta Georgia USA – name: 3 Statistical Research and Applications Branch Surveillance Research Program Division of Cancer Control and Population Sciences National Cancer Institute Bethesda Maryland USA |
| Author_xml | – sequence: 1 givenname: Nikita Sandeep orcidid: 0000-0003-1337-483X surname: Wagle fullname: Wagle, Nikita Sandeep email: nikita.wagle@cancer.org organization: American Cancer Society – sequence: 2 givenname: Leticia orcidid: 0000-0001-6990-3660 surname: Nogueira fullname: Nogueira, Leticia organization: American Cancer Society – sequence: 3 givenname: Theresa P. orcidid: 0000-0002-0348-1407 surname: Devasia fullname: Devasia, Theresa P. organization: National Cancer Institute – sequence: 4 givenname: Angela B. surname: Mariotto fullname: Mariotto, Angela B. organization: National Cancer Institute – sequence: 5 givenname: K. Robin orcidid: 0000-0003-0644-5572 surname: Yabroff fullname: Yabroff, K. Robin organization: American Cancer Society – sequence: 6 givenname: Farhad orcidid: 0000-0002-7357-5994 surname: Islami fullname: Islami, Farhad organization: American Cancer Society – sequence: 7 givenname: Ahmedin surname: Jemal fullname: Jemal, Ahmedin organization: American Cancer Society – sequence: 8 givenname: Rick surname: Alteri fullname: Alteri, Rick organization: American Cancer Society – sequence: 9 givenname: Patricia A. orcidid: 0000-0002-1841-4143 surname: Ganz fullname: Ganz, Patricia A. organization: David Geffen School of Medicine at UCLA – sequence: 10 givenname: Rebecca L. orcidid: 0000-0001-5247-8522 surname: Siegel fullname: Siegel, Rebecca L. organization: American Cancer Society |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40445120$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kUtLw0AUhQdR7EM3_gAJuBExdV7JpCspwRcU3Oh6uJlM7JQ0U2eSSv-9ia1Fi7gaLvOdw7n3DNBhZSuN0BnBI8YovVEAaiQwJuQA9UnEaciTmB2iPsZYhGPKoh4aeD_H3SzEMepxzHlEKO4jmkKltAtqp6Fe6KoOoMoD37iVWVnnZ2YZ-Bpq42uj_HVAMY1O0FEBpden23eIXu_vXtLHcPr88JROpqFqvUkIURELgrMoAj7Os0TxArIkynCeM81wFlMuilxDzLlSqsiAxmJcQCwg4TqGhA3R7cZ32WQLnas2nINSLp1ZgFtLC0b-_qnMTL7ZlSSUUsZi0jpcbh2cfW-0r-XCeKXLEiptGy8ZJZwRLmiHXuyhc9u4qt2vpRgec5GQLtL5z0i7LN_3bIGrDaCc9d7pYocQLLuyZFeW_CqrhfEerEx3a9utY8q_JWQj-TClXv9jLtPJJN1oPgGq0KVx |
| CitedBy_id | crossref_primary_10_1016_j_saa_2025_126932 crossref_primary_10_1007_s00520_025_09905_9 crossref_primary_10_1186_s41065_025_00535_z crossref_primary_10_3389_fimmu_2025_1660034 crossref_primary_10_3322_caac_70017 crossref_primary_10_3390_gastroent16030034 crossref_primary_10_3389_fvets_2025_1552345 crossref_primary_10_3389_fmed_2025_1659090 crossref_primary_10_1038_s41598_025_13085_1 crossref_primary_10_1002_pon_70235 |
| Cites_doi | 10.1007/s10549‐020‐06067‐6 10.3322/caac.21731 10.1016/j.annonc.2022.05.009 10.1007/s00384‐018‐3171‐y 10.1056/NEJMoa2203690 10.1093/jnci/djy136 10.1056/NEJMra1406184 10.1016/S0140‐6736(23)02705‐8 10.1136/bmj.38516.649537.E0 10.1093/jnci/djad139 10.3322/caac.21837 10.3322/caac.21871 10.1182/blood‐2018‐10‐881961 10.1182/blood‐2019‐129919 10.1016/j.urology.2020.06.087 10.1503/cmaj.151276 10.1200/JCO.21.02567 10.1056/NEJMoa1510795 10.1001/jamanetworkopen.2024.62365 10.3322/caac.21812 10.1002/cncr.32546 10.21037/jtd‐21‐433 10.1056/NEJMoa2216334 10.1007/s40487‐020‐00117‐1 10.1200/jco‐24‐01935 10.1002/ajh.26822 10.3322/canjclin.57.4.242 10.1016/j.cllc.2021.01.007 10.1093/jsxmed/qdad119 10.1016/j.gore.2022.100922 10.1001/jamahealthforum.2024.5436 10.1186/s12885‐024‐11894‐7 10.1016/s2542‐5196(18)30168‐2 10.1245/s10434‐017‐6306‐4 10.1056/NEJMoa1809064 10.1001/jama.2025.0228 10.1053/j.gastro.2017.11.005 10.1038/s41408‐021‐00514‐3 10.1016/S0140‐6736(22)00323‐3 10.1016/s0140‐6736(23)00020‐x 10.1245/s10434‐021‐11304‐3 10.1200/CCI.20.00134 10.1158/1055‐9965.Epi‐22‐1234 10.6004/jnccn.2023.0050 10.1002/cncr.35057 10.1001/jamaoncol.2020.2259 10.1001/jamanetworkopen.2025.0413 10.1097/ju.0000000000003694 10.1200/JCO.2017.73.7932 10.1111/bju.12121 10.1200/jco.19.02318 10.3390/cancers14215390 10.1002/ueg2.12658 10.1200/JCO.2017.74.2049 10.1093/jnci/djac005 10.1002/cncr.33601 10.1200/edbk_438466 10.1001/jamasurg.2020.3325 10.1001/jama.2024.19462 10.1001/jamanetworkopen.2024.29760 10.1017/S1478951512000594 10.1038/leu.2014.229 10.1007/s11764‐014‐0354‐6 10.1016/j.ygyno.2020.03.016 10.1200/OP.21.00525 10.1056/NEJMms2025396 10.1002/cncr.27852 10.1093/jnci/djac134 10.1200/edbk_323525 10.1056/NEJMoa1702900 10.1016/j.jaccao.2024.08.006 10.1200/JCO.2017.76.4431 10.1007/s10549‐021‐06311‐7 10.1056/NEJMoa2105215 10.1056/NEJMoa1713709 10.1016/j.ygyno.2011.03.010 10.1016/j.sxmr.2017.11.003 10.1182/blood‐2017‐09‐797712 10.1016/s1470‐2045(22)00635‐0 10.1158/1055‐9965.EPI‐24‐0849 10.1001/jamapediatrics.2015.4689 10.1200/JCO.2015.64.3809 10.1016/s1470‐2045(21)00147‐9 10.1093/jnci/djae135 10.1001/jama.2023.1946 10.1001/jamaoncol.2024.0860 10.1136/bmj‐2023‐076743 10.6004/jnccn.2019.7369 10.3322/caac.21863 10.3390/cancers15010141 10.3389/fonc.2023.1067289 10.1093/ejcts/ezx415 10.1007/s00345‐023‐04418‐8 10.1245/s10434‐022‐11725‐8 10.1001/jamasurg.2020.0322 10.1016/j.breast.2018.08.105 10.1093/jnci/dju186 10.1002/cncr.31913 10.1002/cncr.30597 10.1038/s41375‐021‐01164‐x 10.1038/s41392‐023‐01469‐6 10.1016/s1470‐2045(23)00148‐1 10.21037/tau.2019.09.38 10.1016/j.jsxm.2016.05.005 10.1038/s41571‐019‐0218‐0 10.1001/jamaoncol.2019.4489 10.1159/000516114 10.1038/s41391‐024‐00815‐1 10.1200/op.23.00747 10.3390/curroncol29030150 10.1016/j.jtho.2021.02.024 10.21037/tau‐23‐124 10.1016/j.ygyno.2021.02.037 10.1002/cam4.3429 10.1093/jnci/djx140 10.1001/jama.2021.0106 10.1200/jco.21.01841 10.1097/MLR.0000000000001280 10.1016/j.lungcan.2018.12.028 10.1002/pon.3118 10.1097/ncc.0000000000000785 10.1200/JCO.18.01764 10.1377/hlthaff.2017.0134 10.1200/jco.19.02242 10.1056/NEJMoa2402604 10.3390/cancers15133310 10.1016/j.jiac.2016.05.006 10.1016/j.ajog.2018.08.002 10.1016/j.ajog.2021.10.031 10.1177/1357633x211051677 10.1089/thy.2020.0944 10.1056/NEJMoa2022485 10.1016/j.euf.2018.09.020 10.1001/jamacardio.2016.2132 10.1200/jco.21.02538 10.1016/j.urology.2020.10.039 10.1002/onco.13870 10.1200/JCO.2013.49.3205 10.1016/S0140‐6736(19)33018‐1 10.1200/JCO.2018.78.1914 10.1016/j.jpainsymman.2022.05.016 10.1016/j.amepre.2015.08.008 10.1016/j.ajog.2020.02.041 10.1080/14737140.2020.1732213 10.1093/jnci/djab192 10.1002/cncr.20910 10.1200/jco.23.00539 10.1245/s10434‐016‐5443‐5 10.3389/fimmu.2023.1138483 10.1001/jama.2023.25881 10.1001/jama.2024.27122 10.1001/jamaoncol.2024.1549 10.1007/s11764‐022‐01268‐y 10.1007/s10549‐013‐2745‐1 10.1002/ajh.27443 10.1158/1055‐9965.Epi‐24‐1750 10.6004/jnccn.2023.7114 10.1182/blood.2024024166 10.1007/s11764‐017‐0660‐x 10.1370/afm.2498 10.1056/NEJMsb1305469 10.1093/jncics/pkaa123 10.1007/s10549‐020‐05644‐z 10.1002/phar.2168 10.1093/bjsopen/zrae040 10.1056/NEJMoa2107322 10.1053/j.seminoncol.2020.02.007 10.1016/j.ctrv.2015.09.001 10.1001/jama.2024.12848 10.1002/cncr.32675 10.1158/1055‐9965.Epi‐18‐1280 10.3322/caac.21719 10.1002/cam4.1383 10.1016/j.jtho.2020.09.011 10.1056/NEJMoa1910549 10.1016/S1470‐2045(17)30186‐9 10.1056/NEJMoa2028485 10.1002/sim.1304 10.1093/jnci/djad205 10.1073/pnas.1617464114 10.1007/s11523‐023‐00951‐z 10.1080/07347332.2018.1522411 10.5489/cuaj.221 10.1002/cncr.35515 10.1016/S0140‐6736(22)01188‐6 10.1016/j.sxmr.2021.10.005 10.1002/ajh.26550 10.1002/cncr.33913 10.1093/jnci/djab196 10.1016/S0140‐6736(12)62187‐4 10.1200/JOP.2016.017210 10.1007/978-0-387-88441-7 10.1016/j.eururo.2011.06.049 10.1056/NEJMoa1704174 10.1001/jamaoncol.2023.4952 10.6004/jnccn.2018.0012 10.1200/PO.21.00245 10.1001/jamaoncol.2023.2144 10.1089/thy.2014.0335 10.1016/S1470‐2045(13)70251‐1 10.1016/S1470‐2045(20)30666‐5 10.1200/JCO.19.00382 10.1245/s10434‐019‐07213‐1 10.1002/pon.5657 10.1056/NEJMra1703481 10.1089/jayao.2017.0089 10.1001/jama.2019.7657 10.1200/jco.22.01951 10.1002/ajh.27470 10.1089/thy.2015.0020 10.7326/M21‐0252 10.1007/s10549‐017‐4555‐3 10.1093/jnci/djv439 10.1200/JCO.2008.19.8150 10.1200/JCO.2018.36.15_suppl.3594 10.1016/j.jss.2020.12.057 10.1093/jnci/djab184 10.1200/JCO.2017.75.8995 10.1371/journal.pmed.1003842 10.1136/thoraxjnl‐2018‐212456 10.1177/23743735221077524 10.1038/s41598‐022‐07592‐8 10.1093/annonc/mdz056 10.1200/edbk_390442 10.1200/edbk_280817 10.1007/s10549‐006‐9479‐2 10.1200/JCO.2016.70.5400 10.1016/S0140‐6736(23)00821‐8 10.1056/NEJMoa1911440 10.1007/s00520‐018‐4268‐0 10.1016/j.bjps.2019.08.011 10.1158/1055‐9965.Epi‐24‐1228 10.1200/GO.20.00423 10.1093/jnci/djac158 10.1056/NEJMoa2302312 10.1038/s41467‐020‐16970‐7 10.1056/NEJMoa2401361 10.1200/JCO.20.01330 10.1158/1055‐9965.EPI‐12‐0740 10.1001/jamanetworkopen.2021.12214 10.1200/JCO.19.00151 10.1016/j.annonc.2021.09.001 10.3322/caac.21772 10.1001/jama.2020.17598 10.18632/oncotarget.21059 10.1056/NEJMra1501993 10.1037/a0034216 10.1200/JCO.19.02896 10.1016/S1470‐2045(24)00157‐8 10.1200/JCO.21.01681 10.1038/s41408‐021‐00425‐3 10.1002/cam4.2092 |
| ContentType | Journal Article |
| Copyright | 2025 The Author(s). CA: A Cancer Journal for Clinicians published by Wiley Periodicals LLC on behalf of American Cancer Society. Copyright Wiley Subscription Services, Inc. 2025 |
| Copyright_xml | – notice: 2025 The Author(s). CA: A Cancer Journal for Clinicians published by Wiley Periodicals LLC on behalf of American Cancer Society. – notice: Copyright Wiley Subscription Services, Inc. 2025 |
| DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 7TO 7U9 8FD FR3 H94 K9. NAPCQ P64 RC3 7X8 5PM |
| DOI | 10.3322/caac.70011 |
| DatabaseName | Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts Technology Research Database Engineering Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Nursing & Allied Health Premium Genetics Abstracts Virology and AIDS Abstracts Oncogenes and Growth Factors Abstracts Technology Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Engineering Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
| DatabaseTitleList | MEDLINE CrossRef Nursing & Allied Health Premium MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Statistics Public Health |
| DocumentTitleAlternate | Cancer treatment and survivorship statistics, 2025 |
| EISSN | 1542-4863 |
| EndPage | 340 |
| ExternalDocumentID | PMC12223361 40445120 10_3322_caac_70011 CAAC70011 |
| Genre | article Journal Article |
| GeographicLocations | United States United States--US |
| GeographicLocations_xml | – name: United States – name: United States--US |
| GroupedDBID | .GA .GJ .Y3 0R~ 10A 18M 1CY 1OC 23N 24P 2WC 31~ 4.4 41~ 50Y 50Z 51W 51X 52M 52N 52P 52R 52S 52T 52X 53G 5GY 5RE 5VS 66C 6J9 6PF 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAEVG AAFWJ AAONW AAWTL AAZKR ABCQN ABEML ACBNA ACCMX ACGFO ACPRK ACSCC ACXQS ADBBV ADIZJ ADPDF ADXAS AEGXH AEIMD AFBPY AFFNX AFZJQ AHMBA AI. AIAGR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR ATUGU AZBYB BAFTC BAWUL BFHJK BKOMP BY8 C1A CS3 D-6 D-7 D-E D-F DCZOG DIK DR2 E3Z EBD EBS EIHBH EJD EMB EMOBN F00 F01 F04 F5P FAS FJW G-S GODZA GX1 H.X HZ~ IX1 J0M KQ8 L7B LC2 LC3 LH4 LW6 N04 N05 NF~ O66 O9- OHT OK1 OVD OVT P2P P2W P2X P2Z PQQKQ Q.N Q11 QB0 ROL RWL RX1 RXW SJN SUPJJ SV3 TAE TEORI TR2 TWZ UB1 UDS VH1 W2D W8V WH7 WHWMO WOHZO WOQ WQJ WVDHM WXI XG1 XSB XV2 XZL YQJ ZCG ZGI ZVN ZXP ~WT 1OB AAYXX CITATION O8X WIN CGR CUY CVF ECM EIF NPM 7T5 7TO 7U9 8FD FR3 H94 K9. NAPCQ P64 RC3 7X8 5PM |
| ID | FETCH-LOGICAL-c4511-a5f6710b55a49db8c4fab85b0dd3e30b6247fdea644cccfba2679fa67a84e6a83 |
| IEDL.DBID | 24P |
| ISICitedReferencesCount | 35 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001499809500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0007-9235 1542-4863 |
| IngestDate | Tue Sep 30 17:02:15 EDT 2025 Fri Sep 05 15:57:20 EDT 2025 Fri Oct 03 02:51:41 EDT 2025 Sun Sep 14 01:40:34 EDT 2025 Sat Nov 29 06:53:04 EST 2025 Tue Nov 18 21:46:56 EST 2025 Thu Jul 03 09:30:27 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Keywords | prevalence survivorship treatment patterns statistics |
| Language | English |
| License | Attribution-NonCommercial-NoDerivs 2025 The Author(s). CA: A Cancer Journal for Clinicians published by Wiley Periodicals LLC on behalf of American Cancer Society. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4511-a5f6710b55a49db8c4fab85b0dd3e30b6247fdea644cccfba2679fa67a84e6a83 |
| Notes | The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the National Cancer Institute. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0002-7357-5994 0000-0003-1337-483X 0000-0001-6990-3660 0000-0003-0644-5572 0000-0001-5247-8522 0000-0002-0348-1407 0000-0002-1841-4143 |
| OpenAccessLink | https://onlinelibrary.wiley.com/doi/abs/10.3322%2Fcaac.70011 |
| PMID | 40445120 |
| PQID | 3230947818 |
| PQPubID | 6515 |
| PageCount | 33 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_12223361 proquest_miscellaneous_3214314721 proquest_journals_3230947818 pubmed_primary_40445120 crossref_primary_10_3322_caac_70011 crossref_citationtrail_10_3322_caac_70011 wiley_primary_10_3322_caac_70011_CAAC70011 |
| PublicationCentury | 2000 |
| PublicationDate | 2025-08-01 |
| PublicationDateYYYYMMDD | 2025-08-01 |
| PublicationDate_xml | – month: 08 year: 2025 text: 2025-08-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: Atlanta – name: Hoboken |
| PublicationTitle | CA: a cancer journal for clinicians |
| PublicationTitleAlternate | CA Cancer J Clin |
| PublicationYear | 2025 |
| Publisher | Wiley Subscription Services, Inc John Wiley and Sons Inc |
| Publisher_xml | – name: Wiley Subscription Services, Inc – name: John Wiley and Sons Inc |
| References | 2020; 20 2013; 369 2021; 325 2019; 17 2019; 16 2024; 30 2020; 11 2025; 75 2020; 18 2013; 119 2019; 21 2019; 26 2015; 373 2019; 28 2024; 20 2018; 219 2024; 22 2024; 24 2024; 25 2024; 27 2012; 21 2011; 122 2025; 333 2020; 383 2020; 382 2019; 30 2024; 403 2019; 34 2019; 37 2020; 38 2024; 10 2017; 130 2023; 329 2024; 12 2017; 377 2024; 18 2016; 13 2018; 111 2017; 53 2016; 1 2022; 6 2020; 395 2022; 9 2020; 155 2022; 97 2020; 157 2016; 26 2016; 23 2016; 22 2023; 32 2013; 22 2016; 108 2021; 127 2020; 126 2024; 74 2024; 384 2024; 143 2020; 58 2017; 110 2017; 114 2023; 20 2020; 8 2023; 21 2020; 6 2023; 24 2020; 4 2013; 14 2013; 11 2021; 113 2000 2017; 36 2021; 114 2017; 35 2020; 9 2020; 47 2020; 43 2017; 123 2014; 8 2024; 390 2024; 391 2022; 400 2021; 5 2025; 131 2023; 13 2023; 14 2021; 4 2019; 72 2023; 12 2023; 18 2019; 74 2010 2023; 15 2021; 226 2023; 402 2023; 401 2020; 223 2007; 57 2023 2013; 33 2022 2021 2020 2002; 21 2017; 13 2013; 31 2016; 375 2024; 42 2016; 374 2016 2017; 18 2024; 44 2023; 73 2007; 106 2005; 331 2011; 60 2018; 167 2022; 23 2020; 324 2019; 322 2021; 161 2025 2024 2013; 7 2018; 42 2022; 29 2018; 7 2018; 6 2018; 2 2024; 6 2024; 116 2024; 8 2022; 40 2024; 7 2005; 103 2021; 151 2022; 33 2018; 38 2018; 36 2019; 8 2025; 6 2025; 8 2021; 149 2021; 384 2021; 262 2024; 99 2021; 385 2018; 26 2018; 25 2022; 114 2023; 41 2022; 12 2024; 130 2022; 14 2022; 15 2022; 10 2018; 12 2016; 170 2018; 16 2022; 18 2015; 34 2021; 26 2017; 8 2021; 22 2022; 72 2023; 8 2023; 388 2023; 9 2016; 188 2019; 125 2022; 64 2021; 30 2021; 35 2021; 32 2021; 31 2015; 49 2021; 39 2015; 41 2018; 379 2018; 378 Mar 2019; 129 2022; 128 2021; 190 2023; 98 2020; 181 2013; 142 2021; 187 2013; 381 2009; 27 2022; 399 2014; 113 2022; 387 2021; 13 2021; 16 2018; 154 2015; 25 2014; 106 2021; 11 2015; 29 2021; 18 2023; 115 2024; 331 2024; 332 2021; 174 2024; 211 2019; 133 2019; 134 e_1_2_9_79_1 e_1_2_9_254_1 e_1_2_9_94_1 e_1_2_9_10_1 e_1_2_9_56_1 e_1_2_9_239_1 e_1_2_9_33_1 e_1_2_9_216_1 e_1_2_9_71_1 e_1_2_9_231_1 e_1_2_9_107_1 e_1_2_9_122_1 e_1_2_9_168_1 e_1_2_9_183_1 e_1_2_9_160_1 e_1_2_9_265_1 e_1_2_9_22_1 e_1_2_9_45_1 e_1_2_9_68_1 e_1_2_9_83_1 e_1_2_9_204_1 e_1_2_9_227_1 e_1_2_9_6_1 e_1_2_9_119_1 e_1_2_9_60_1 e_1_2_9_242_1 e_1_2_9_111_1 e_1_2_9_134_1 e_1_2_9_157_1 e_1_2_9_195_1 National Comprehensive Cancer Network (NCCN) (e_1_2_9_98_1) 2024 e_1_2_9_172_1 e_1_2_9_232_1 e_1_2_9_72_1 e_1_2_9_34_1 e_1_2_9_57_1 e_1_2_9_217_1 e_1_2_9_270_1 e_1_2_9_129_1 e_1_2_9_144_1 e_1_2_9_167_1 e_1_2_9_106_1 e_1_2_9_121_1 e_1_2_9_182_1 e_1_2_9_61_1 e_1_2_9_243_1 Surveillance, Epidemiology, and End Results (SEER) Program (e_1_2_9_8_1) 2024 e_1_2_9_46_1 e_1_2_9_84_1 e_1_2_9_228_1 e_1_2_9_266_1 e_1_2_9_205_1 e_1_2_9_5_1 e_1_2_9_220_1 e_1_2_9_118_1 e_1_2_9_133_1 e_1_2_9_156_1 e_1_2_9_179_1 National Comprehensive Cancer Network (NCCN) (e_1_2_9_174_1) 2024 National Cancer Institute (e_1_2_9_9_1) 2022 e_1_2_9_69_1 e_1_2_9_110_1 e_1_2_9_171_1 e_1_2_9_194_1 e_1_2_9_31_1 e_1_2_9_210_1 e_1_2_9_256_1 e_1_2_9_233_1 e_1_2_9_77_1 e_1_2_9_54_1 e_1_2_9_92_1 e_1_2_9_109_1 e_1_2_9_271_1 e_1_2_9_101_1 US Food and Drug Administration (FDA) (e_1_2_9_95_1) 2021 e_1_2_9_124_1 e_1_2_9_147_1 e_1_2_9_39_1 e_1_2_9_162_1 e_1_2_9_218_1 e_1_2_9_16_1 e_1_2_9_185_1 e_1_2_9_89_1 e_1_2_9_221_1 e_1_2_9_244_1 e_1_2_9_43_1 e_1_2_9_66_1 e_1_2_9_206_1 e_1_2_9_267_1 Amin MB (e_1_2_9_11_1) 2016 e_1_2_9_81_1 e_1_2_9_113_1 e_1_2_9_159_1 e_1_2_9_136_1 e_1_2_9_151_1 e_1_2_9_197_1 e_1_2_9_28_1 e_1_2_9_229_1 e_1_2_9_211_1 e_1_2_9_234_1 e_1_2_9_257_1 Surveillance, Epidemiology, and End Results (SEER) Program (e_1_2_9_19_1) 2024 e_1_2_9_78_1 e_1_2_9_32_1 e_1_2_9_55_1 e_1_2_9_272_1 e_1_2_9_93_1 e_1_2_9_108_1 e_1_2_9_70_1 e_1_2_9_100_1 e_1_2_9_123_1 e_1_2_9_169_1 e_1_2_9_146_1 Surveillance Research Program, National Cancer Institute (e_1_2_9_20_1) 2024 e_1_2_9_219_1 e_1_2_9_17_1 e_1_2_9_184_1 e_1_2_9_161_1 e_1_2_9_245_1 e_1_2_9_222_1 e_1_2_9_67_1 e_1_2_9_44_1 e_1_2_9_268_1 e_1_2_9_260_1 e_1_2_9_7_1 e_1_2_9_82_1 American College of Surgeons Commission on Cancer (e_1_2_9_12_1) 2024 e_1_2_9_112_1 e_1_2_9_135_1 e_1_2_9_158_1 e_1_2_9_207_1 e_1_2_9_173_1 e_1_2_9_196_1 e_1_2_9_29_1 e_1_2_9_150_1 e_1_2_9_75_1 e_1_2_9_190_1 e_1_2_9_52_1 e_1_2_9_235_1 e_1_2_9_212_1 e_1_2_9_258_1 e_1_2_9_90_1 e_1_2_9_250_1 e_1_2_9_103_1 e_1_2_9_126_1 e_1_2_9_149_1 Surveillance, Epidemiology, and End Results (SEER) Program (e_1_2_9_154_1) 2023 e_1_2_9_141_1 e_1_2_9_187_1 e_1_2_9_37_1 e_1_2_9_164_1 e_1_2_9_41_1 e_1_2_9_64_1 e_1_2_9_87_1 e_1_2_9_200_1 e_1_2_9_223_1 e_1_2_9_246_1 e_1_2_9_269_1 Golla V (e_1_2_9_188_1) 2019; 21 e_1_2_9_2_1 e_1_2_9_261_1 e_1_2_9_138_1 e_1_2_9_115_1 e_1_2_9_199_1 e_1_2_9_26_1 e_1_2_9_49_1 e_1_2_9_208_1 e_1_2_9_130_1 e_1_2_9_176_1 e_1_2_9_153_1 e_1_2_9_191_1 e_1_2_9_30_1 e_1_2_9_53_1 e_1_2_9_99_1 e_1_2_9_213_1 Fritz A (e_1_2_9_14_1) 2000 e_1_2_9_236_1 e_1_2_9_259_1 e_1_2_9_76_1 e_1_2_9_91_1 Surveillance, Epidemiology, and End Results (SEER) Program (e_1_2_9_21_1) 2023 e_1_2_9_251_1 e_1_2_9_102_1 e_1_2_9_148_1 US Food and Drug Administration (FDA) (e_1_2_9_96_1) 2021 e_1_2_9_125_1 e_1_2_9_15_1 e_1_2_9_38_1 e_1_2_9_140_1 e_1_2_9_163_1 e_1_2_9_186_1 e_1_2_9_42_1 e_1_2_9_88_1 e_1_2_9_224_1 e_1_2_9_201_1 e_1_2_9_65_1 e_1_2_9_247_1 e_1_2_9_80_1 e_1_2_9_262_1 e_1_2_9_114_1 e_1_2_9_137_1 US Food and Drug Administration (FDA) (e_1_2_9_145_1) 2024 e_1_2_9_152_1 e_1_2_9_175_1 e_1_2_9_198_1 e_1_2_9_27_1 e_1_2_9_50_1 e_1_2_9_73_1 e_1_2_9_35_1 e_1_2_9_214_1 e_1_2_9_237_1 e_1_2_9_252_1 Surveillance, Epidemiology, and End Results (SEER) Program (e_1_2_9_18_1) 2024 e_1_2_9_128_1 e_1_2_9_166_1 e_1_2_9_105_1 e_1_2_9_189_1 e_1_2_9_120_1 e_1_2_9_58_1 e_1_2_9_143_1 e_1_2_9_181_1 e_1_2_9_62_1 e_1_2_9_202_1 e_1_2_9_24_1 e_1_2_9_85_1 e_1_2_9_225_1 e_1_2_9_248_1 National Academies of Sciences, Engineering, and Medicine (e_1_2_9_255_1) 2021 e_1_2_9_4_1 National Comprehensive Cancer Network (NCCN) (e_1_2_9_209_1) 2025 e_1_2_9_263_1 e_1_2_9_240_1 e_1_2_9_117_1 e_1_2_9_155_1 e_1_2_9_178_1 e_1_2_9_47_1 e_1_2_9_132_1 e_1_2_9_193_1 e_1_2_9_170_1 e_1_2_9_74_1 e_1_2_9_51_1 Howlader N (e_1_2_9_23_1) 2021 e_1_2_9_215_1 e_1_2_9_238_1 e_1_2_9_13_1 e_1_2_9_97_1 e_1_2_9_230_1 e_1_2_9_253_1 e_1_2_9_127_1 e_1_2_9_104_1 e_1_2_9_36_1 e_1_2_9_59_1 e_1_2_9_142_1 e_1_2_9_165_1 e_1_2_9_180_1 e_1_2_9_63_1 e_1_2_9_40_1 e_1_2_9_203_1 e_1_2_9_249_1 e_1_2_9_86_1 e_1_2_9_226_1 e_1_2_9_264_1 e_1_2_9_3_1 e_1_2_9_241_1 e_1_2_9_139_1 e_1_2_9_116_1 e_1_2_9_177_1 e_1_2_9_25_1 e_1_2_9_131_1 e_1_2_9_48_1 e_1_2_9_192_1 40944902 - CA Cancer J Clin. 2025 Sep 13. doi: 10.3322/caac.70036. |
| References_xml | – volume: 378 start-page: 1177 issue: 13 year: 2018 end-page: 1188 article-title: Duration of adjuvant chemotherapy for stage III colon cancer publication-title: N Engl J Med – volume: 333 start-page: 793 issue: 9 year: 2025 end-page: 803 article-title: Testicular germ cell tumors: a review publication-title: JAMA – volume: 49 start-page: S477 issue: 6 suppl 5 year: 2015 end-page: S482 article-title: Advancing health equity in cancer survivorship: opportunities for public health publication-title: Am J Prev Med – volume: 15 issue: 1 year: 2022 article-title: BRAF and MEK inhibitors and their toxicities: a meta‐analysis publication-title: Cancers (Basel) – volume: 4 issue: 6 year: 2021 article-title: Time trends in use of radical prostatectomy by tumor risk and life expectancy in a national Veterans Affairs cohort publication-title: JAMA Netw Open – volume: 22 start-page: 919 issue: 7 year: 2021 end-page: 930 article-title: Pembrolizumab monotherapy for the treatment of high‐risk non‐muscle‐invasive bladder cancer unresponsive to BCG (KEYNOTE‐057): an open‐label, single‐arm, multicentre, phase 2 study publication-title: Lancet Oncol – volume: 38 start-page: 999 issue: 10 year: 2018 end-page: 1009 article-title: Risks of major long‐term side effects associated with androgen‐deprivation therapy in men with prostate cancer publication-title: Pharmacotherapy – volume: 6 start-page: 1461 year: 2020 end-page: 1471 article-title: Delivering cancer care during the COVID‐19 pandemic: recommendations and lessons learned from ASCO global webinars publication-title: JCO Glob Oncol – volume: 74 start-page: 136 issue: 2 year: 2024 end-page: 166 article-title: American Cancer Society's report on the status of cancer disparities in the United States, 2023 publication-title: CA Cancer J Clin – volume: 13 year: 2023 article-title: Advances in the treatment of Hodgkin lymphoma: current and future approaches publication-title: Front Oncol – volume: 6 year: 2022 article-title: Landscape of KRAS G12C, associated genomic alterations, and interrelation with immuno‐oncology biomarkers in KRAS‐mutated cancers publication-title: JCO Precis Oncol – volume: 14 start-page: 873 issue: 9 year: 2013 end-page: 881 article-title: Infertility, infertility treatment, and achievement of pregnancy in female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort publication-title: Lancet Oncol – volume: 181 start-page: 487 issue: 3 year: 2020 end-page: 497 article-title: Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID‐19 pandemic. The COVID‐19 pandemic breast cancer consortium publication-title: Breast Cancer Res Treat – volume: 114 start-page: 4582 issue: 18 year: 2017 end-page: 4590 article-title: Adapt to more wildfire in western North American forests as climate changes publication-title: Proc Natl Acad Sci U S A – volume: 29 start-page: 1828 issue: 3 year: 2022 end-page: 1839 article-title: Non‐small‐cell lung cancer in 2022: a review for general practitioners in oncology publication-title: Curr Oncol – volume: 131 issue: 1 year: 2025 article-title: Proximity to cancer rehabilitation and exercise oncology by geography, race, and socioeconomic status publication-title: Cancer – start-page: 418 issue: 40 year: 2020 end-page: 435 article-title: On the shoulders of giants: the evolution of renal cell carcinoma treatment—cytokines, targeted therapy, and immunotherapy publication-title: Am Soc Clin Oncol Educ Book – volume: 21 start-page: 145 issue: 4 year: 2019 end-page: 153 article-title: Intravesical therapy for non‐muscle invasive bladder cancer—current and future options in the age of bacillus Calmette–Guerin shortage publication-title: Rev Urol – volume: 114 start-page: 160 issue: 1 year: 2022 end-page: 164 article-title: Patient‐reported functional outcomes in patients with chronic myeloid leukemia after stopping tyrosine kinase inhibitors publication-title: J Natl Cancer Inst – volume: 30 start-page: 807 issue: 6 year: 2021 end-page: 817 article-title: A literature review of post‐treatment survivorship interventions for colorectal cancer survivors and/or their caregivers publication-title: Psychooncology – volume: 18 start-page: 169 issue: 3 year: 2022 end-page: 172 article-title: Incorporating reproductive health in the clinical management of early‐onset colorectal cancer publication-title: JCO Oncol Pract – volume: 12 start-page: 802 issue: 5 year: 2023 end-page: 808 article-title: Bladder‐sparing approaches for muscle invasive bladder cancer: a narrative review of current evidence and future perspectives publication-title: Transl Androl Urol – volume: 29 start-page: 2527 issue: 4 year: 2022 end-page: 2536 article-title: The impact of Commission on Cancer accreditation status, hospital rurality and hospital size on quality measure performance rates publication-title: Ann Surg Oncol – volume: 20 start-page: 1319 issue: 11 year: 2023 end-page: 1324 article-title: Intimacy and survivors of cancer with ostomies: findings from the Ostomy Self‐Management Training trial publication-title: J Sex Med – year: 2025 – volume: 377 start-page: 352 issue: 4 year: 2017 end-page: 360 article-title: Abiraterone plus prednisone in metastatic, castration‐sensitive prostate cancer publication-title: N Engl J Med – volume: 10 start-page: 885 issue: 7 year: 2024 end-page: 886 article-title: Cardiovascular risk in prostate cancer—a call to action? publication-title: JAMA Oncol – volume: 9 start-page: 1214 issue: 9 year: 2023 end-page: 1220 article-title: Association of wildfire exposure while recovering from lung cancer surgery with overall survival publication-title: JAMA Oncol – volume: 74 start-page: 466 issue: 5 year: 2019 end-page: 472 article-title: Incidence of second and higher order smoking‐related primary cancers following lung cancer: a population‐based cohort study publication-title: Thorax – year: 2025 article-title: Trend and provider‐ and organizational‐level factors associated with early palliative care billing among patients diagnosed with distant‐stage cancers in 2010–2019 in the United States publication-title: J Clin Oncol – volume: 106 issue: 8 year: 2014 article-title: Developing interventions for cancer‐related cognitive dysfunction in childhood cancer survivors publication-title: J Natl Cancer Inst – volume: 47 start-page: 23 issue: 1 year: 2020 end-page: 39 article-title: Current and coming challenges in the management of the survivorship population publication-title: Semin Oncol – volume: 155 start-page: 1035 issue: 11 year: 2020 end-page: 1042 article-title: Association of breast cancer surgery with quality of life and psychosocial well‐being in young breast cancer survivors publication-title: JAMA Surg – volume: 31 start-page: 337 issue: 3 year: 2021 end-page: 386 article-title: 2021 American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer publication-title: Thyroid – volume: 125 start-page: 1737 issue: 10 year: 2019 end-page: 1747 article-title: Medical financial hardship among cancer survivors in the United States publication-title: Cancer – volume: 72 start-page: 409 issue: 5 year: 2022 end-page: 436 article-title: Cancer treatment and survivorship statistics, 2022 publication-title: CA Cancer J Clin – volume: 332 start-page: 1001 issue: 12 year: 2024 end-page: 1010 article-title: Renal cell carcinoma: a review publication-title: JAMA – volume: 22 start-page: e303 issue: 7 year: 2021 end-page: e313 article-title: Evidence‐based approaches for the management of side‐effects of adjuvant endocrine therapy in patients with breast cancer publication-title: Lancet Oncol – volume: 6 start-page: 907 issue: 6 year: 2024 end-page: 918 article-title: Cardiovascular disease with hormone therapy and ovarian suppression in premenopausal breast cancer survivors publication-title: JACC CardioOncol – volume: 30 start-page: 706 issue: 5 year: 2019 end-page: 720 article-title: Renal cell carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow‐up publication-title: Ann Oncol – volume: 6 start-page: 1465 issue: 9 year: 2020 end-page: 1468 article-title: Race disparities in proton radiotherapy uses for cancer treatment in patients enrolled in Children's Oncology Group trials publication-title: JAMA Oncol – volume: 384 start-page: 2394 issue: 25 year: 2021 end-page: 2405 article-title: Adjuvant olaparib for patients with ‐ or ‐mutated breast Cancer publication-title: N Engl J Med – volume: 36 issue: 15 suppl year: 2018 article-title: International harmonization of diagnostic criteria for HER2‐amplified metastatic colorectal cancer and application of targeted next‐generation sequencing panel as a diagnostic method [abstract] publication-title: J Clin Oncol – volume: 37 start-page: 1895 issue: 22 year: 2019 end-page: 1908 article-title: Hysterectomy‐corrected uterine corpus cancer incidence trends and differences in relative survival reveal racial disparities and rising rates of nonendometrioid cancers publication-title: J Clin Oncol – volume: 12 start-page: 216 issue: 2 year: 2018 end-page: 223 article-title: Posttraumatic stress‐related psychological functioning in adult survivors of childhood cancer publication-title: J Cancer Surviv – volume: 190 start-page: 549 issue: 3 year: 2021 end-page: 558 article-title: Racial/ethnic disparities in risk of breast cancer mortality by molecular subtype and stage at diagnosis publication-title: Breast Cancer Res Treat – volume: 26 start-page: 845 issue: 10 year: 2021 end-page: 853 article-title: The prognostic impact of KRAS G12C mutation in patients with metastatic colorectal cancer: a multicenter retrospective observational study publication-title: Oncologist – volume: 130 start-page: 2373 issue: 22 year: 2017 end-page: 2376 article-title: Gemtuzumab ozogamicin for acute myeloid leukemia publication-title: Blood – volume: 10 start-page: 874 issue: 7 year: 2024 end-page: 884 article-title: Cardiovascular events and androgen receptor signaling inhibitors in advanced prostate cancer: a systematic review and meta‐analysis publication-title: JAMA Oncol – volume: 388 start-page: 2159 issue: 23 year: 2023 end-page: 2170 article-title: Pembrolizumab plus chemotherapy in advanced endometrial cancer publication-title: N Engl J Med – volume: 33 start-page: 1261 issue: 10 year: 2013 end-page: 1272 article-title: CHESS improves cancer caregivers' burden and mood: results of an eHealth RCT publication-title: Health Psychol – volume: 6 start-page: 344 issue: 2 year: 2020 end-page: 353 article-title: The predictive role of biomarkers for the detection of acute kidney injury after partial or radical nephrectomy: a systematic review of the literature publication-title: Eur Urol Focus – volume: 42 start-page: 1368 issue: 12 year: 2024 end-page: 1377 article-title: Racial disparities in receipt of guideline‐concordant care for early‐onset colorectal cancer in the United States publication-title: J Clin Oncol – volume: 1 start-page: 1066 issue: 9 year: 2016 end-page: 1072 article-title: Oncocardiology—past, present, and future: a review publication-title: JAMA Cardiol – start-page: 147 issue: 41 year: 2021 end-page: 157 article-title: Management of long‐term toxicity from pelvic radiation therapy publication-title: Am Soc Clin Oncol Educ Book – volume: 385 start-page: 1091 issue: 12 year: 2021 end-page: 1103 article-title: Lutetium‐177–PSMA‐617 for metastatic castration‐resistant prostate cancer publication-title: N Engl J Med – volume: 8 issue: 3 year: 2025 article-title: Exercise and psychosexual education to improve sexual function in men with prostate cancer: a randomized clinical trial publication-title: JAMA Netw Open – volume: 38 start-page: 2341 issue: 20 year: 2020 end-page: 2350 article-title: Breast cancer‐related lymphedema: risk factors, screening, management, and the impact of locoregional treatment publication-title: J Clin Oncol – volume: 119 start-page: 1235 issue: 6 year: 2013 end-page: 1242 article-title: Surveillance after resection for colorectal cancer publication-title: Cancer – volume: 8 issue: 3 year: 2024 article-title: Overall survival after mastectomy versus breast‐conserving surgery with adjuvant radiotherapy for early‐stage breast cancer: meta‐analysis publication-title: BJS Open – volume: 399 start-page: 1412 issue: 10333 year: 2022 end-page: 1428 article-title: Endometrial cancer publication-title: Lancet – volume: 22 start-page: e691 issue: 5 year: 2021 end-page: e698 article-title: Racial disparities in overall survival and surgical treatment for early stage lung cancer by facility type publication-title: Clin Lung Cancer – volume: 401 start-page: 1531 issue: 10387 year: 2023 end-page: 1544 article-title: Thyroid cancer publication-title: Lancet – volume: 34 start-page: 611 issue: 6 year: 2015 end-page: 635 article-title: American Cancer Society/American Society of Clinical Oncology breast cancer survivorship care guideline publication-title: J Clin Oncol – volume: 22 start-page: 1200 issue: 6 year: 2013 end-page: 1207 article-title: A systematic review of psychosocial interventions to improve cancer caregiver quality of life publication-title: Psychooncology – volume: 113 start-page: 11 issue: 1 year: 2014 end-page: 23 article-title: Urinary diversion after radical cystectomy for bladder cancer: options, patient selection, and outcomes publication-title: BJU Int – volume: 134 issue: suppl 1 year: 2019 article-title: A report on 114 patients who experienced treatment free remission in a single institution during a 15 years period: long term follow‐up, late molecular relapses and second attempts [abstract] publication-title: Blood – volume: 22 start-page: 244 issue: 4 year: 2024 end-page: 248 article-title: Loneliness and mortality risk among cancer survivors in the United States: a retrospective, longitudinal study publication-title: J Natl Compr Cancer Netw – volume: 391 start-page: 1696 issue: 18 year: 2024 end-page: 1708 article-title: Neoadjuvant nivolumab and ipilimumab in resectable stage III melanoma publication-title: N Engl J Med – volume: 262 start-page: 71 year: 2021 end-page: 84 article-title: Trends in contralateral prophylactic mastectomy utilization for small unilateral breast cancer publication-title: J Surg Res – volume: 381 start-page: 1943 issue: 9881 year: 2013 end-page: 1955 article-title: Acute lymphoblastic leukaemia publication-title: Lancet – volume: 116 start-page: 208 issue: 2 year: 2024 end-page: 215 article-title: Cancer and COVID‐19: US cancer incidence rates during the first year of the pandemic publication-title: J Natl Cancer Inst – volume: 98 start-page: 502 issue: 3 year: 2023 end-page: 526 article-title: Acute myeloid leukemia: 2023 update on diagnosis, risk‐stratification, and management publication-title: Am J Hematol – volume: 9 start-page: 8310 issue: 22 year: 2020 end-page: 8317 article-title: Race modifies survival benefit of guideline‐based treatment: implications for reducing disparities in muscle invasive bladder cancer publication-title: Cancer Med – volume: 15 issue: 13 year: 2023 article-title: Treatment of nodular lymphocyte‐predominant Hodgkin lymphoma: where do we stand? Where do we go? publication-title: Cancers (Basel) – volume: 8 start-page: 261 issue: 2 year: 2020 end-page: 275 article-title: Overall survival improved for contemporary patients with melanoma: a 2004–2015 National Cancer Database analysis publication-title: Oncol Ther – year: 2021 – volume: 27 start-page: 1214 issue: 8 year: 2009 end-page: 1219 article-title: Safety of ovarian preservation in premenopausal women with endometrial cancer publication-title: J Clin Oncol – volume: 41 start-page: 3104 issue: 17 year: 2023 end-page: 3109 article-title: Impact of heatwaves on cancer care delivery: potential mechanisms, health equity concerns, and adaptation strategies publication-title: J Clin Oncol – volume: 103 start-page: 1457 issue: 7 year: 2005 end-page: 1467 article-title: International Classification of Childhood Cancer, third edition publication-title: Cancer – volume: 40 start-page: 1439 issue: 13 year: 2022 end-page: 1449 article-title: Association between radioactive iodine treatment for pediatric and young adulthood differentiated thyroid cancer and risk of second primary malignancies publication-title: J Clin Oncol – volume: 31 start-page: 3673 issue: 29 year: 2013 end-page: 3680 article-title: Modifiable risk factors and major cardiac events among adult survivors of childhood cancer publication-title: J Clin Oncol – volume: 11 issue: 6 year: 2021 article-title: Acute promyelocytic leukemia current treatment algorithms publication-title: Blood Cancer J – volume: 35 start-page: 893 issue: 8 year: 2017 end-page: 911 article-title: Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline publication-title: J Clin Oncol – volume: 37 start-page: 1 issue: 4 year: 2019 end-page: 14 article-title: Is it time to reconsider the term “cancer survivor?” publication-title: J Psychosoc Oncol – volume: 331 start-page: 233 issue: 3 year: 2024 end-page: 241 article-title: Analysis of breast cancer mortality in the US—1975 to 2019 publication-title: JAMA – volume: 22 start-page: 505 issue: 8 year: 2016 end-page: 514 article-title: An overview of infectious complications after allogeneic hematopoietic stem cell transplantation publication-title: J Infect Chemother – volume: 111 start-page: 498 issue: 5 year: 2018 end-page: 508 article-title: Endocrine therapy nonadherence and discontinuation in Black and White women publication-title: J Natl Cancer Inst – volume: 16 start-page: 310 issue: 3 year: 2018 end-page: 320 article-title: Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology publication-title: J Natl Compr Canc Netw – volume: 18 start-page: 352 issue: 2 year: 2024 end-page: 365 article-title: Primary care provider–led cancer survivorship care in the first 5 years following initial cancer treatment: a scoping review of the barriers and solutions to implementation publication-title: J Cancer Surviv – volume: 226 start-page: 541.e1 issue: 4 year: 2021 end-page: 541.e13 article-title: Disparities in adjuvant treatment of high‐grade endometrial cancer in the Medicare population publication-title: Am J Obstet Gynecol – volume: 379 start-page: 2220 issue: 23 year: 2018 end-page: 2229 article-title: First‐line atezolizumab plus chemotherapy in extensive‐stage small‐cell lung cancer publication-title: N Engl J Med – volume: 41 start-page: 1497 issue: 6 year: 2023 end-page: 1502 article-title: Changing nationwide trends away from overtreatment among patients undergoing radical prostatectomy over the past 25 years publication-title: World J Urol – volume: 35 start-page: 651 issue: 3 year: 2021 end-page: 660 article-title: Two decades of targeted therapies in acute myeloid leukemia publication-title: Leukemia – volume: 60 start-page: 615 issue: 4 year: 2011 end-page: 621 article-title: The epidemiology of renal cell carcinoma publication-title: Eur Urol – volume: 7 start-page: E552 issue: 9‐10 year: 2013 end-page: E560 article-title: Updated assessment of neobladder utilization and morbidity according to urinary diversion after radical cystectomy: a contemporary US‐population–based cohort publication-title: Can Urol Assoc J – volume: 375 start-page: 1054 issue: 11 year: 2016 end-page: 1067 article-title: Biologic and clinical perspectives on thyroid cancer publication-title: N Engl J Med – volume: 26 start-page: 1 issue: 1 year: 2016 end-page: 133 article-title: 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer publication-title: Thyroid – volume: 108 issue: 7 year: 2016 article-title: Chimeric antigen receptors modified T‐cells for cancer therapy publication-title: J Natl Cancer Inst – volume: 29 start-page: 5925 issue: 9 year: 2022 end-page: 5932 article-title: Incidence of second primary melanoma in cutaneous melanoma survivors publication-title: Ann Surg Oncol – volume: 18 issue: 10 year: 2021 article-title: Association of race and health insurance in treatment disparities of colon cancer: a retrospective analysis utilizing a national population database in the United States publication-title: PLoS Med – volume: 384 year: 2024 article-title: Advances in diagnosis and treatment of bladder cancer publication-title: BMJ – volume: 32 start-page: 869 issue: 7 year: 2023 end-page: 875 article-title: Climate change and cancer publication-title: Cancer Epidemiol Biomarkers Prev – volume: 21 start-page: 3511 issue: 22 year: 2002 end-page: 3526 article-title: Estimation and projections of cancer prevalence from cancer registry data publication-title: Stat Med – volume: 12 start-page: 1489 issue: 10 year: 2024 end-page: 1506 article-title: Guideline for the assessment and management of gastrointestinal symptoms following colorectal surgery—a UEG/ESCP/EAES/ESPCG/ESPEN/ESNM/ESSO collaboration. Part I—sequelae to oncological diseases publication-title: United European Gastroenterol J – volume: 384 start-page: 768 issue: 8 year: 2021 end-page: 773 article-title: How structural racism works—racist policies as a root cause of U.S. racial health inequities publication-title: N Engl J Med – volume: 11 start-page: 231 issue: 3 year: 2013 end-page: 252 article-title: Care for the cancer caregiver: a systematic review publication-title: Palliat Support Care – volume: 133 start-page: 1548 issue: 14 year: 2019 end-page: 1559 article-title: A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403 publication-title: Blood – volume: 4 start-page: 1059 year: 2020 end-page: 1071 article-title: Impact of COVID‐19 on cancer care: how the pandemic is delaying cancer diagnosis and treatment for American seniors publication-title: JCO Clin Cancer Inform – volume: 383 start-page: 2345 issue: 24 year: 2020 end-page: 2357 article-title: Survival with olaparib in metastatic castration‐resistant prostate cancer publication-title: N Engl J Med – volume: 8 issue: 2 year: 2025 article-title: Physical health decline after chemotherapy or endocrine therapy in breast cancer survivors publication-title: JAMA Netw Open – volume: 155 start-page: 759 issue: 8 year: 2020 end-page: 770 article-title: Deimplementation of the Choosing Wisely recommendations for low‐value breast cancer surgery: a systematic review publication-title: JAMA Surg – volume: 74 start-page: 477 issue: 6 year: 2024 end-page: 495 article-title: Breast cancer statistics 2024 publication-title: CA Cancer J Clin – volume: 18 start-page: 202 issue: 3 year: 2020 end-page: 209 article-title: Cancer survivorship care roles for primary care physicians publication-title: Ann Fam Med – volume: 36 start-page: 492 issue: 5 year: 2018 end-page: 511 article-title: Interventions to address sexual problems in people with cancer: American Society of Clinical Oncology clinical practice guideline adaptation of Cancer Care Ontario guideline publication-title: J Clin Oncol – volume: 5 issue: 1 year: 2021 article-title: Factors associated with health‐related quality of life among cancer survivors in the United States publication-title: JNCI Cancer Spectr – volume: 23 start-page: 1497 issue: 12 year: 2022 end-page: 1498 article-title: Climate‐driven Atlantic hurricanes create complex challenges for cancer care publication-title: Lancet Oncol – volume: 20 start-page: 159 issue: 3 year: 2020 end-page: 166 article-title: Contralateral prophylactic mastectomy in breast cancer: what to discuss with patients publication-title: Expert Rev Anticancer Ther – volume: 17 start-page: 1557 issue: 12 year: 2019 end-page: 1568 article-title: Testicular cancer survivorship publication-title: J Natl Compr Canc Netw – volume: 53 start-page: 835 issue: 4 year: 2017 end-page: 841 article-title: A proposal for a comprehensive risk scoring system for predicting postoperative complications in octogenarian patients with medically operable lung cancer: JACS1303 publication-title: Eur J Cardiothorac Surg – volume: 211 start-page: 20 issue: 1 year: 2024 end-page: 25 article-title: Diagnosis and treatment of early‐stage testicular cancer: AUA guideline amendment 2023 publication-title: J Urol – volume: 32 start-page: 1552 issue: 12 year: 2021 end-page: 1570 article-title: The efficacy, challenges, and facilitators of telemedicine in post‐treatment cancer survivorship care: an overview of systematic reviews publication-title: Ann Oncol – volume: 8 start-page: 3325 issue: 6 year: 2019 end-page: 3335 article-title: Racial differences in patterns of treatment among men diagnosed with de novo advanced prostate cancer: a SEER‐Medicare investigation publication-title: Cancer Med – volume: 40 start-page: 892 issue: 8 year: 2022 end-page: 910 article-title: Adjuvant therapy for stage II colon cancer: ASCO guideline update publication-title: J Clin Oncol – volume: 369 start-page: 2347 issue: 24 year: 2013 end-page: 2351 article-title: Early specialty palliative care—translating data in oncology into practice publication-title: N Engl J Med – volume: 377 start-page: 338 issue: 4 year: 2017 end-page: 351 article-title: Abiraterone for prostate cancer not previously treated with hormone therapy publication-title: N Engl J Med – volume: 24 start-page: 443 issue: 5 year: 2023 end-page: 456 article-title: Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol publication-title: Lancet Oncol – volume: 13 start-page: 233 issue: 4 year: 2017 end-page: 241 article-title: Adjuvant chemotherapy for stage II colon cancer: a clinical dilemma publication-title: J Oncol Pract – volume: 11 issue: 1 year: 2020 article-title: Increasing trends in regional heatwaves publication-title: Nat Commun – volume: 43 start-page: E132 issue: 3 year: 2020 end-page: E158 article-title: Symptom experiences in colorectal cancer survivors after cancer treatments: a systematic review and meta‐analysis publication-title: Cancer Nurs – volume: 64 start-page: 254 issue: 3 year: 2022 end-page: 267 article-title: Postoperative symptom burden in patients undergoing lung cancer surgery publication-title: J Pain Symptom Manag – volume: 10 start-page: 134 issue: 1 year: 2024 end-page: 137 article-title: Distribution of cancer care resources across US hospitals by patient race and ethnicity publication-title: JAMA Oncol – volume: 44 issue: 3 year: 2024 article-title: State‐of‐the‐art management of colorectal cancer: treatment advances and innovation publication-title: Am Soc Clin Oncol Educ Book – volume: 99 start-page: 2367 issue: 12 year: 2024 end-page: 2378 article-title: Hodgkin lymphoma: 2025 update on diagnosis, risk‐stratification, and management publication-title: Am J Hematol – volume: 114 start-page: 1593 issue: 12 year: 2022 end-page: 1600 article-title: Addressing transportation insecurity among patients with cancer publication-title: J Natl Cancer Inst – volume: 329 start-page: 918 issue: 11 year: 2023 end-page: 932 article-title: Diagnosis and treatment of chronic lymphocytic leukemia: a review publication-title: JAMA – year: 2025 article-title: A polygenic risk score for late bladder toxicity following radiotherapy for non‐metastatic prostate cancer publication-title: Cancer Epidemiol Biomarkers Prev – volume: 16 start-page: 135 issue: 2 year: 2021 end-page: 143 article-title: St. Gallen/Vienna 2021: a brief summary of the consensus discussion on customizing therapies for women with early breast cancer publication-title: Breast Care (Basel) – volume: 114 start-page: 419 issue: 3 year: 2021 end-page: 426 article-title: Real‐world use of bone modifying agents in metastatic castration‐sensitive prostate cancer publication-title: J Natl Cancer Inst – volume: 115 start-page: 1252 issue: 11 year: 2023 end-page: 1261 article-title: Protecting vulnerable patient populations from climate hazards: the role of the nation's cancer centers publication-title: J Natl Cancer Inst – issue: 43 year: 2023 article-title: Advances in the management of menopausal symptoms, fertility preservation, and bone health for women with breast cancer on endocrine therapy publication-title: Am Soc Clin Oncol Educ Book – volume: 122 start-page: 63 issue: 1 year: 2011 end-page: 68 article-title: Insurance status and racial differences in uterine cancer survival: a study of patients in the National Cancer Database publication-title: Gynecol Oncol – volume: 332 start-page: 1924 issue: 22 year: 2024 end-page: 1935 article-title: CAR T cells and T‐cell therapies for cancer: a translational science review publication-title: JAMA – volume: 129 start-page: 1 year: Mar 2019 end-page: 7 article-title: Longitudinal study to assess impact of smoking at diagnosis and quitting on 1‐year survival for people with non‐small cell lung cancer publication-title: Lung Cancer – volume: 72 start-page: 230 issue: 3 year: 2022 end-page: 262 article-title: American Cancer Society nutrition and physical activity guideline for cancer survivors publication-title: CA Cancer J Clin – volume: 23 start-page: 3100 issue: 10 year: 2016 end-page: 3105 article-title: Contralateral prophylactic mastectomy (CPM) consensus statement from the American Society of Breast Surgeons: data on CPM outcomes and risks publication-title: Ann Surg Oncol – volume: 6 issue: 3 year: 2020 article-title: The role of maintenance strategies in metastatic colorectal cancer: a systematic review and network meta‐analysis of randomized clinical trials publication-title: JAMA Oncol – volume: 219 start-page: 459e1 issue: 5 year: 2018 end-page: 459e11 article-title: Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 study publication-title: Am J Obstet Gynecol – year: 2022 – volume: 28 start-page: 1339 issue: 8 year: 2019 end-page: 1344 article-title: Social determinants of appropriate treatment for muscle‐invasive bladder cancer publication-title: Cancer Epidemiol Biomarkers Prev – volume: 9 start-page: 3056 issue: 6 year: 2020 end-page: 3072 article-title: Transurethral resection of bladder tumour (TURBT) publication-title: Transl Androl Urol – volume: 99 start-page: 2191 issue: 11 year: 2024 end-page: 2212 article-title: Chronic myeloid leukemia: 2025 update on diagnosis, therapy, and monitoring publication-title: Am J Hematol – volume: 18 start-page: 247 issue: 2 year: 2023 end-page: 255 article-title: Analysis of anti‐angiogenesis‐related adverse events associated with vascular endothelial growth factor receptor‐tyrosine kinase inhibitors (VEGFR‐TKIs) in patients with metastatic renal cell carcinoma publication-title: Target Oncol – volume: 157 start-page: 716 issue: 3 year: 2020 end-page: 722 article-title: Guideline‐concordant treatment is associated with improved survival among women with non‐endometrioid endometrial cancer publication-title: Gynecol Oncol – volume: 36 start-page: 25 issue: 1 year: 2018 end-page: 33 article-title: Racial and ethnic disparities in cancer survival: the contribution of tumor, sociodemographic, institutional, and neighborhood characteristics publication-title: J Clin Oncol – volume: 73 start-page: 233 issue: 3 year: 2023 end-page: 254 article-title: Colorectal cancer statistics, 2023 publication-title: CA Cancer J Clin – year: 2025 article-title: National Cancer Institute‐funded cancer epidemiology survivor cohorts: overview, progress, and opportunities publication-title: Cancer Epidemiol Biomarkers Prev – volume: 126 start-page: 487 issue: 3 year: 2020 end-page: 495 article-title: Fertility preservation before breast cancer treatment appears unlikely to affect disease‐free survival at a median follow‐up of 43 months after fertility‐preservation consultation publication-title: Cancer – volume: 34 start-page: 239 issue: 2 year: 2019 end-page: 245 article-title: Trends and outcomes of sphincter‐preserving surgery for rectal cancer: a National Cancer Database study publication-title: Int J Colorectal Dis – volume: 74 start-page: 341 issue: 4 year: 2024 end-page: 358 article-title: Cancer diagnosis and treatment in working‐age adults: implications for employment, health insurance coverage, and financial hardship in the United States publication-title: CA Cancer J Clin – volume: 403 start-page: 1791 issue: 10438 year: 2024 end-page: 1807 article-title: B‐cell non‐Hodgkin lymphomas publication-title: Lancet – volume: 18 start-page: 719 issue: 6 year: 2017 end-page: 731 article-title: International incidence of childhood cancer, 2001–10: a population‐based registry study publication-title: Lancet Oncol – volume: 388 start-page: 2145 issue: 23 year: 2023 end-page: 2158 article-title: Dostarlimab for primary advanced or recurrent endometrial cancer publication-title: N Engl J Med – volume: 161 start-page: 470 issue: 2 year: 2021 end-page: 476 article-title: Racial disparities in high‐risk uterine cancer histologic subtypes: a United States Cancer Statistics study publication-title: Gynecol Oncol – volume: 40 year: 2022 article-title: Disparities in cancer‐specific and overall survival in Black women with endometrial cancer: a Medicare‐SEER study publication-title: Gynecol Oncol Rep – volume: 41 start-page: 925 issue: 10 year: 2015 end-page: 934 article-title: Intermediate and long‐term adverse effects of radioiodine therapy for differentiated thyroid carcinoma—a systematic review publication-title: Cancer Treat Rev – volume: 8 start-page: 83280 issue: 47 year: 2017 end-page: 83291 article-title: Incidence and relative risk of cutaneous squamous cell carcinoma with single‐agent BRAF inhibitor and dual BRAF/MEK inhibitors in cancer patients: a meta‐analysis publication-title: Oncotarget – volume: 151 start-page: 154 year: 2021 end-page: 162 article-title: Sex and racial disparities in the treatment and outcomes of muscle‐invasive bladder cancer publication-title: Urology – volume: 6 issue: 2 year: 2025 article-title: Contemporary patterns of end‐of‐life care among Medicare beneficiaries with advanced cancer publication-title: JAMA Health Forum – volume: 36 start-page: 1994 issue: 19 year: 2018 end-page: 2001 article-title: Fertility preservation in patients with cancer: ASCO clinical practice guideline update publication-title: J Clin Oncol – volume: 130 start-page: 375 issue: 3 year: 2024 end-page: 384 article-title: Sexual Health Assessment in Women with Lung Cancer study: sexual health assessment in women with lung cancer publication-title: Cancer – volume: 20 start-page: 899 issue: 7 year: 2024 end-page: 906 article-title: An era of advances in systemic therapies for advanced thyroid cancer publication-title: JCO Oncol Pract – volume: 26 start-page: 1604 issue: 6 year: 2019 end-page: 1612 article-title: Incident cases captured in the National Cancer Database compared with those in U.S. population based central cancer registries in 2012–2014 publication-title: Ann Surg Oncol – volume: 167 start-page: 761 issue: 3 year: 2018 end-page: 769 article-title: Safety of fertility preservation in breast cancer patients in a register‐based matched cohort study publication-title: Breast Cancer Res Treat – volume: 13 start-page: 3566 issue: 6 year: 2021 end-page: 3586 article-title: The effect of the enhanced recovery after surgery program on lung cancer surgery: a systematic review and meta‐analysis publication-title: J Thorac Dis – volume: 154 start-page: 906 issue: 4 year: 2018 end-page: 915e7 article-title: Factors that contribute to differences in survival of Black vs White patients with colorectal cancer publication-title: Gastroenterology – volume: 39 start-page: 631 issue: 6 year: 2021 end-page: 641 article-title: Duration of adjuvant doublet chemotherapy (3 or 6 months) in patients with high‐risk stage II colorectal cancer publication-title: J Clin Oncol – volume: 106 start-page: 85 issue: 1 year: 2007 end-page: 95 article-title: Possible socioeconomic and ethnic disparities in quality of life in a cohort of breast cancer survivors publication-title: Breast Cancer Res Treat – volume: 142 start-page: 465 issue: 3 year: 2013 end-page: 476 article-title: Contralateral prophylactic mastectomy and survival: report from the National Cancer Data Base, 1998–2002 publication-title: Breast Cancer Res Treat – volume: 72 start-page: 1956 issue: 12 year: 2019 end-page: 1962 article-title: Risk factors for post‐operative complications after sentinel lymph node biopsy for cutaneous melanoma: results from a large cohort study publication-title: J Plast Reconstr Aesthet Surg – volume: 36 start-page: 1184 issue: 7 year: 2017 end-page: 1192 article-title: A national profile of end‐of‐life caregiving in the United States publication-title: Health Aff (Millwood) – year: 2016 – volume: 114 start-page: 1476 issue: 11 year: 2022 end-page: 1483 article-title: Estimation of the number of individuals living with metastatic cancer in the United States publication-title: J Natl Cancer Inst – year: 2010 – volume: 14 issue: 21 year: 2022 article-title: Minimising the toxicities of first line Hodgkin lymphoma treatment in the modern era publication-title: Cancers (Basel) – volume: 127 start-page: 3872 issue: 20 year: 2021 end-page: 3880 article-title: The impact of fertility preservation on the timing of breast cancer treatment, recurrence, and survival publication-title: Cancer – volume: 26 start-page: 3933 issue: 11 year: 2018 end-page: 3939 article-title: Ongoing ostomy self‐care challenges of long‐term rectal cancer survivors publication-title: Support Care Cancer – volume: 29 start-page: 526 issue: 3 year: 2015 end-page: 534 article-title: Long‐term outcome of a pediatric‐inspired regimen used for adults aged 18–50 years with newly diagnosed acute lymphoblastic leukemia publication-title: Leukemia – volume: 116 start-page: 1784 issue: 11 year: 2024 end-page: 1790 article-title: Prevalence of cancer survivors in the United States publication-title: J Natl Cancer Inst – volume: 27 start-page: 765 issue: 4 year: 2024 end-page: 775 article-title: Emerging racial disparities among Medicare beneficiaries and veterans with metastatic castration‐sensitive prostate cancer publication-title: Prostate Cancer Prostatic Dis – volume: 36 start-page: 2198 issue: 21 year: 2018 end-page: 2205 article-title: Financial hardship and the economic effect of childhood cancer survivorship publication-title: J Clin Oncol – volume: 10 start-page: 231 issue: 2 year: 2022 end-page: 239 article-title: Female sexual function following radical cystectomy in bladder cancer publication-title: Sex Med Rev – volume: 374 start-page: 833 issue: 9 year: 2016 end-page: 842 article-title: Reduction in late mortality among 5‐year survivors of childhood cancer publication-title: N Engl J Med – volume: 9 year: 2022 article-title: The effect of major and minor complications after lung surgery on length of stay and readmission publication-title: J Patient Exp – volume: 174 start-page: 1232 issue: 9 year: 2021 end-page: 1239 article-title: Postdiagnosis smoking cessation and reduced risk for lung cancer progression and mortality: a prospective cohort study publication-title: Ann Intern Med – volume: 128 start-page: 222 issue: 2 year: 2022 end-page: 229 article-title: Cancer‐related impairments and functional limitations among long‐term cancer survivors: gaps and opportunities for clinical practice publication-title: Cancer – volume: 110 issue: 2 year: 2017 article-title: Chemotherapy‐associated peripheral neuropathy in patients with early‐stage breast cancer: a systematic review publication-title: J Natl Cancer Inst – volume: 390 start-page: 2047 issue: 22 year: 2024 end-page: 2060 article-title: Risk of second tumors and T‐cell lymphoma after CAR T‐cell therapy publication-title: N Engl J Med – volume: 395 start-page: 1146 issue: 10230 year: 2020 end-page: 1162 article-title: Acute lymphoblastic leukaemia publication-title: Lancet – volume: 126 start-page: 949 issue: 5 year: 2020 end-page: 957 article-title: Systematic review of barriers and facilitators to clinical trial enrollment among adolescents and young adults with cancer: identifying opportunities for intervention publication-title: Cancer – volume: 58 start-page: 392 issue: 4 year: 2020 end-page: 398 article-title: Racial disparities in resection of early stage non‐small cell lung cancer: variability among surgeons publication-title: Med Care – volume: 2 start-page: e370 issue: 9 year: 2018 end-page: e371 article-title: The 2017 perfect storm season, climate change, and environmental injustice publication-title: Lancet Planet Health – volume: 37 start-page: 1090 issue: 13 year: 2019 end-page: 1101 article-title: Therapy‐related cardiac risk in childhood cancer survivors: an analysis of the Childhood Cancer Survivor Study publication-title: J Clin Oncol – volume: 57 start-page: 242 issue: 4 year: 2007 end-page: 255 article-title: Young adult oncology: the patients and their survival challenges publication-title: CA Cancer J Clin – volume: 7 start-page: 1118 issue: 4 year: 2018 end-page: 1126 article-title: Adult nodular lymphocyte‐predominant Hodgkin lymphoma: treatment modality utilization and survival publication-title: Cancer Med – volume: 402 start-page: 485 issue: 10400 year: 2023 end-page: 502 article-title: Cutaneous melanoma publication-title: Lancet – year: 2024 – volume: 187 start-page: 275 issue: 1 year: 2021 end-page: 285 article-title: Fatigue, anxiety, and quality of life in breast cancer patients compared to non‐cancer controls: a nationwide longitudinal analysis publication-title: Breast Cancer Res Treat – volume: 6 start-page: 469 issue: 3 year: 2018 end-page: 481 article-title: Surgical factors associated with male and female sexual dysfunction after radical cystectomy: what do we know and how can we improve outcomes? publication-title: Sex Med Rev – volume: 42 start-page: 113 year: 2018 end-page: 127 article-title: Prevalence of pain in patients with breast cancer post‐treatment: a systematic review publication-title: Breast – volume: 40 start-page: 2004 issue: 18 year: 2022 end-page: 2012 article-title: Prophylactic use of compression sleeves reduces the incidence of arm swelling in women at high risk of breast cancer‐related lymphedema: a randomized controlled trial publication-title: J Clin Oncol – volume: 75 start-page: 10 issue: 1 year: 2025 end-page: 45 article-title: Cancer statistics, 2025 publication-title: CA Cancer J Clin – volume: 40 issue: 9 year: 2022 article-title: Prospective surveillance for breast cancer‐related arm lymphedema: a systematic review and meta‐analysis publication-title: J Clin Oncol – volume: 325 start-page: 669 issue: 7 year: 2021 end-page: 685 article-title: Diagnosis and treatment of metastatic colorectal cancer: a review publication-title: JAMA – year: 2025 article-title: Patterns of change in emotional and functional well‐being following breast cancer diagnosis publication-title: Cancer Epidemiol Biomarkers Prev – volume: 16 start-page: 563 issue: 9 year: 2019 end-page: 580 article-title: Adverse effects of immune‐checkpoint inhibitors: epidemiology, management and surveillance publication-title: Nat Rev Clin Oncol – volume: 324 start-page: 1980 issue: 19 year: 2020 end-page: 1991 article-title: Bladder cancer: a review publication-title: JAMA – volume: 25 start-page: 720 issue: 3 year: 2018 end-page: 728 article-title: Decreased use of sphincter‐preserving procedures among African Americans with rectal cancer publication-title: Ann Surg Oncol – volume: 149 start-page: 11 year: 2021 end-page: 20 article-title: Side effects of intravesical BCG and chemotherapy for bladder cancer: what they are and how to manage them publication-title: Urology – volume: 387 start-page: 9 issue: 1 year: 2022 end-page: 20 article-title: Trastuzumab deruxtecan in previously treated HER2‐low advanced breast cancer publication-title: N Engl J Med – volume: 12 issue: 1 year: 2022 article-title: Radioactive iodine and female fertility publication-title: Sci Rep – volume: 25 start-page: 811 issue: 6 year: 2024 end-page: 822 article-title: The burden of cardiovascular disease and risk for subsequent major adverse cardiovascular events in survivors of childhood cancer: a prospective, longitudinal analysis from the St Jude Lifetime Cohort Study publication-title: Lancet Oncol – volume: 38 start-page: 1258 issue: 12 year: 2020 end-page: 1267 article-title: Improving adjuvant endocrine treatment tailoring in premenopausal women with hormone receptor–positive breast cancer publication-title: J Clin Oncol – volume: 33 start-page: 860 issue: 9 year: 2022 end-page: 877 article-title: Endometrial cancer: ESMO clinical practice guideline for diagnosis, treatment and follow‐up publication-title: Ann Oncol – volume: 384 start-page: 1529 issue: 16 year: 2021 end-page: 1541 article-title: Sacituzumab govitecan in metastatic triple‐negative breast cancer publication-title: N Engl J Med – volume: 13 start-page: 1071 issue: 7 year: 2016 end-page: 1079 article-title: Sexual function and health‐related quality of life in long‐term rectal cancer survivors publication-title: J Sex Med – volume: 113 start-page: 1670 issue: 12 year: 2021 end-page: 1682 article-title: Annual Report to the Nation on the Status of Cancer, part 2: patient economic burden associated with cancer care publication-title: J Natl Cancer Inst – volume: 170 issue: 5 year: 2016 article-title: Cancer in adolescents and young adults: a narrative review of the current status and a view of the future publication-title: JAMA Pediatr – volume: 16 start-page: 151 issue: 1 year: 2021 end-page: 155 article-title: A 10‐year cross‐sectional analysis of public, oncologist, and patient attitudes about lung cancer and associated stigma publication-title: J Thorac Oncol – volume: 36 start-page: 14 issue: 1 year: 2018 end-page: 24 article-title: Factors that contributed to Black–White disparities in survival among nonelderly women with breast cancer between 2004 and 2013 publication-title: J Clin Oncol – volume: 30 start-page: 90 issue: 1 year: 2024 end-page: 97 article-title: Disparities in telehealth utilization during the COVID‐19 pandemic: findings from a nationally representative survey in the United States publication-title: J Telemed Telecare – volume: 24 issue: 1 year: 2024 article-title: Health‐related risk behaviors among U.S. childhood cancer survivors: a nationwide estimate publication-title: BMC Cancer – volume: 400 start-page: 1712 issue: 10364 year: 2022 end-page: 1721 article-title: Current best practice for bladder cancer: a narrative review of diagnostics and treatments publication-title: Lancet – volume: 38 start-page: 1887 issue: 17 year: 2020 end-page: 1896 article-title: Antitumor activity and safety of trastuzumab deruxtecan in patients with HER2‐low–expressing advanced breast cancer: results from a phase Ib study publication-title: J Clin Oncol – volume: 25 start-page: 567 issue: 6 year: 2015 end-page: 610 article-title: Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma publication-title: Thyroid – volume: 37 start-page: 1519 issue: 18 year: 2019 end-page: 1523 article-title: Who are the patients in our clinical trials for cancer? publication-title: J Clin Oncol – year: 2000 – volume: 11 issue: 2 year: 2021 article-title: Acute myeloid leukemia: current progress and future directions publication-title: Blood Cancer J – volume: 21 start-page: 2108 issue: 11 year: 2012 end-page: 2117 article-title: Mental and physical health‐related quality of life among U.S. cancer survivors: population estimates from the 2010 National Health Interview Survey publication-title: Cancer Epidemiol Biomarkers Prev – volume: 7 start-page: 358 issue: 3 year: 2018 end-page: 366 article-title: Self‐perceived physical attractiveness in relation to scars among adolescent and young adult cancer survivors: a population‐based study publication-title: J Adolesc Young Adult Oncol – volume: 382 start-page: 810 issue: 9 year: 2020 end-page: 821 article-title: Pembrolizumab for early triple‐negative breast cancer publication-title: N Engl J Med – volume: 14 year: 2023 article-title: Immune‐related pulmonary toxicities of checkpoint inhibitors in non‐small cell lung cancer: diagnosis, mechanism, and treatment strategies publication-title: Front Immunol – volume: 331 issue: 7515 year: 2005 article-title: Skin biopsy rates and incidence of melanoma: population based ecological study publication-title: BMJ – volume: 21 start-page: 1067 issue: 10 year: 2023 end-page: 1096 article-title: Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology publication-title: J Natl Compr Cancer Netw – year: 2025 article-title: Prostate cancer: a review publication-title: JAMA – volume: 16 start-page: 968 issue: 6 year: 2021 end-page: 979 article-title: Tobacco smoking and risk of second primary lung cancer publication-title: J Thorac Oncol – volume: 97 start-page: 856 issue: 7 year: 2022 end-page: 864 article-title: Treatment‐free remission in patients with chronic myeloid leukemia following the discontinuation of tyrosine kinase inhibitors publication-title: Am J Hematol – volume: 123 start-page: 2320 issue: 12 year: 2017 end-page: 2328 article-title: Future of testicular germ cell tumor incidence in the United States: forecast through 2026 publication-title: Cancer – volume: 223 start-page: 398e1 issue: 3 year: 2020 end-page: 398e18 article-title: Black and Hispanic women are less likely than White women to receive guideline‐concordant endometrial cancer treatment publication-title: Am J Obstet Gynecol – volume: 188 start-page: E352 issue: 14 year: 2016 end-page: E361 article-title: Predictors of persistent pain after breast cancer surgery: a systematic review and meta‐analysis of observational studies publication-title: CMAJ – volume: 143 start-page: 2099 issue: 20 year: 2024 end-page: 2105 article-title: Second primary malignancies after commercial CAR T‐cell therapy: analysis of the FDA Adverse Events Reporting System publication-title: Blood – year: 2023 – volume: 114 start-page: 553 issue: 4 year: 2022 end-page: 564 article-title: Obstetrical and perinatal outcomes in female survivors of childhood and adolescent cancer: a population‐based cohort study publication-title: J Natl Cancer Inst – volume: 8 issue: 1 year: 2023 article-title: Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management publication-title: Signal Transduct Target Ther – volume: 322 start-page: 269 issue: 3 year: 2019 end-page: 271 article-title: Association between declared hurricane disasters and survival of patients with lung cancer undergoing radiation treatment publication-title: JAMA – volume: 378 start-page: 158 issue: 2 year: 2018 end-page: 168 article-title: Immune‐related adverse events associated with immune checkpoint blockade publication-title: N Engl J Med – volume: 8 start-page: 437 issue: 3 year: 2014 end-page: 447 article-title: Male infertility in long‐term survivors of pediatric cancer: a report from the Childhood Cancer Survivor Study publication-title: J Cancer Surviv – volume: 373 start-page: 1136 issue: 12 year: 2015 end-page: 1152 article-title: Acute myeloid leukemia publication-title: N Engl J Med – volume: 382 start-page: 2091 issue: 22 year: 2020 end-page: 2102 article-title: Olaparib for metastatic castration‐resistant prostate cancer publication-title: N Engl J Med – volume: 7 issue: 8 year: 2024 article-title: Trends in active surveillance for men with intermediate‐risk prostate cancer publication-title: JAMA Netw Open – ident: e_1_2_9_62_1 doi: 10.1007/s10549‐020‐06067‐6 – ident: e_1_2_9_130_1 doi: 10.3322/caac.21731 – ident: e_1_2_9_202_1 doi: 10.1016/j.annonc.2022.05.009 – ident: e_1_2_9_76_1 doi: 10.1007/s00384‐018‐3171‐y – ident: e_1_2_9_38_1 doi: 10.1056/NEJMoa2203690 – ident: e_1_2_9_24_1 doi: 10.1093/jnci/djy136 – ident: e_1_2_9_106_1 doi: 10.1056/NEJMra1406184 – ident: e_1_2_9_120_1 doi: 10.1016/S0140‐6736(23)02705‐8 – ident: e_1_2_9_146_1 doi: 10.1136/bmj.38516.649537.E0 – ident: e_1_2_9_249_1 doi: 10.1093/jnci/djad139 – ident: e_1_2_9_270_1 doi: 10.3322/caac.21837 – ident: e_1_2_9_17_1 doi: 10.3322/caac.21871 – ident: e_1_2_9_217_1 doi: 10.1182/blood‐2018‐10‐881961 – ident: e_1_2_9_109_1 doi: 10.1182/blood‐2019‐129919 – ident: e_1_2_9_193_1 doi: 10.1016/j.urology.2020.06.087 – ident: e_1_2_9_50_1 doi: 10.1503/cmaj.151276 – ident: e_1_2_9_47_1 doi: 10.1200/JCO.21.02567 – volume-title: SEER*Stat Database: Incidence year: 2024 ident: e_1_2_9_19_1 – ident: e_1_2_9_219_1 doi: 10.1056/NEJMoa1510795 – ident: e_1_2_9_63_1 doi: 10.1001/jamanetworkopen.2024.62365 – ident: e_1_2_9_231_1 doi: 10.3322/caac.21812 – ident: e_1_2_9_59_1 doi: 10.1002/cncr.32546 – ident: e_1_2_9_134_1 doi: 10.21037/jtd‐21‐433 – volume-title: National Cancer Dabatase, 2023 data submission year: 2024 ident: e_1_2_9_12_1 – ident: e_1_2_9_211_1 doi: 10.1056/NEJMoa2216334 – ident: e_1_2_9_147_1 doi: 10.1007/s40487‐020‐00117‐1 – ident: e_1_2_9_257_1 doi: 10.1200/jco‐24‐01935 – ident: e_1_2_9_102_1 doi: 10.1002/ajh.26822 – ident: e_1_2_9_218_1 doi: 10.3322/canjclin.57.4.242 – ident: e_1_2_9_127_1 doi: 10.1016/j.cllc.2021.01.007 – ident: e_1_2_9_87_1 doi: 10.1093/jsxmed/qdad119 – ident: e_1_2_9_207_1 doi: 10.1016/j.gore.2022.100922 – ident: e_1_2_9_258_1 doi: 10.1001/jamahealthforum.2024.5436 – ident: e_1_2_9_262_1 doi: 10.1186/s12885‐024‐11894‐7 – ident: e_1_2_9_246_1 doi: 10.1016/s2542‐5196(18)30168‐2 – volume-title: AJCC Cancer Staging Manual year: 2016 ident: e_1_2_9_11_1 – ident: e_1_2_9_77_1 doi: 10.1245/s10434‐017‐6306‐4 – ident: e_1_2_9_129_1 doi: 10.1056/NEJMoa1809064 – ident: e_1_2_9_166_1 doi: 10.1001/jama.2025.0228 – ident: e_1_2_9_80_1 doi: 10.1053/j.gastro.2017.11.005 – ident: e_1_2_9_101_1 doi: 10.1038/s41408‐021‐00514‐3 – ident: e_1_2_9_214_1 doi: 10.1016/S0140‐6736(22)00323‐3 – ident: e_1_2_9_181_1 doi: 10.1016/s0140‐6736(23)00020‐x – ident: e_1_2_9_272_1 doi: 10.1245/s10434‐021‐11304‐3 – ident: e_1_2_9_240_1 doi: 10.1200/CCI.20.00134 – ident: e_1_2_9_245_1 doi: 10.1158/1055‐9965.Epi‐22‐1234 – ident: e_1_2_9_153_1 doi: 10.6004/jnccn.2023.0050 – ident: e_1_2_9_142_1 doi: 10.1002/cncr.35057 – ident: e_1_2_9_235_1 doi: 10.1001/jamaoncol.2020.2259 – ident: e_1_2_9_168_1 doi: 10.1001/jamanetworkopen.2025.0413 – ident: e_1_2_9_175_1 doi: 10.1097/ju.0000000000003694 – ident: e_1_2_9_40_1 doi: 10.1200/JCO.2017.73.7932 – ident: e_1_2_9_200_1 doi: 10.1111/bju.12121 – volume-title: NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines), Uterine Neoplasms Version 3.2025 year: 2025 ident: e_1_2_9_209_1 – ident: e_1_2_9_37_1 doi: 10.1200/jco.19.02318 – ident: e_1_2_9_123_1 doi: 10.3390/cancers14215390 – ident: e_1_2_9_81_1 doi: 10.1002/ueg2.12658 – ident: e_1_2_9_41_1 doi: 10.1200/JCO.2017.74.2049 – ident: e_1_2_9_230_1 doi: 10.1093/jnci/djac005 – volume-title: Diagnosing and Treating Adult Cancers and Associated Impairments year: 2021 ident: e_1_2_9_255_1 – ident: e_1_2_9_61_1 doi: 10.1002/cncr.33601 – ident: e_1_2_9_75_1 doi: 10.1200/edbk_438466 – ident: e_1_2_9_54_1 doi: 10.1001/jamasurg.2020.3325 – ident: e_1_2_9_124_1 doi: 10.1001/jama.2024.19462 – ident: e_1_2_9_155_1 doi: 10.1001/jamanetworkopen.2024.29760 – ident: e_1_2_9_264_1 doi: 10.1017/S1478951512000594 – ident: e_1_2_9_114_1 doi: 10.1038/leu.2014.229 – ident: e_1_2_9_229_1 doi: 10.1007/s11764‐014‐0354‐6 – ident: e_1_2_9_205_1 doi: 10.1016/j.ygyno.2020.03.016 – ident: e_1_2_9_90_1 doi: 10.1200/OP.21.00525 – ident: e_1_2_9_232_1 doi: 10.1056/NEJMms2025396 – ident: e_1_2_9_238_1 doi: 10.1002/cncr.27852 – ident: e_1_2_9_30_1 doi: 10.1093/jnci/djac134 – ident: e_1_2_9_82_1 doi: 10.1200/edbk_323525 – ident: e_1_2_9_158_1 doi: 10.1056/NEJMoa1702900 – ident: e_1_2_9_64_1 doi: 10.1016/j.jaccao.2024.08.006 – ident: e_1_2_9_268_1 doi: 10.1200/JCO.2017.76.4431 – ident: e_1_2_9_43_1 doi: 10.1007/s10549‐021‐06311‐7 – ident: e_1_2_9_35_1 doi: 10.1056/NEJMoa2105215 – ident: e_1_2_9_89_1 doi: 10.1056/NEJMoa1713709 – ident: e_1_2_9_212_1 doi: 10.1016/j.ygyno.2011.03.010 – ident: e_1_2_9_199_1 doi: 10.1016/j.sxmr.2017.11.003 – ident: e_1_2_9_104_1 doi: 10.1182/blood‐2017‐09‐797712 – ident: e_1_2_9_247_1 doi: 10.1016/s1470‐2045(22)00635‐0 – ident: e_1_2_9_52_1 doi: 10.1158/1055‐9965.EPI‐24‐0849 – ident: e_1_2_9_225_1 doi: 10.1001/jamapediatrics.2015.4689 – ident: e_1_2_9_46_1 doi: 10.1200/JCO.2015.64.3809 – ident: e_1_2_9_190_1 doi: 10.1016/s1470‐2045(21)00147‐9 – ident: e_1_2_9_2_1 doi: 10.1093/jnci/djae135 – volume-title: SEER*Stat Database: North American Association of Central Cancer Registries (NAACCR) Incidence Data year: 2023 ident: e_1_2_9_21_1 – ident: e_1_2_9_115_1 doi: 10.1001/jama.2023.1946 – ident: e_1_2_9_172_1 doi: 10.1001/jamaoncol.2024.0860 – ident: e_1_2_9_187_1 doi: 10.1136/bmj‐2023‐076743 – ident: e_1_2_9_177_1 doi: 10.6004/jnccn.2019.7369 – ident: e_1_2_9_42_1 doi: 10.3322/caac.21863 – ident: e_1_2_9_151_1 doi: 10.3390/cancers15010141 – ident: e_1_2_9_118_1 doi: 10.3389/fonc.2023.1067289 – ident: e_1_2_9_132_1 doi: 10.1093/ejcts/ezx415 – ident: e_1_2_9_156_1 doi: 10.1007/s00345‐023‐04418‐8 – ident: e_1_2_9_152_1 doi: 10.1245/s10434‐022‐11725‐8 – ident: e_1_2_9_31_1 doi: 10.1001/jamasurg.2020.0322 – ident: e_1_2_9_49_1 doi: 10.1016/j.breast.2018.08.105 – ident: e_1_2_9_223_1 doi: 10.1093/jnci/dju186 – ident: e_1_2_9_269_1 doi: 10.1002/cncr.31913 – ident: e_1_2_9_173_1 doi: 10.1002/cncr.30597 – ident: e_1_2_9_105_1 doi: 10.1038/s41375‐021‐01164‐x – ident: e_1_2_9_122_1 doi: 10.1038/s41392‐023‐01469‐6 – ident: e_1_2_9_159_1 doi: 10.1016/s1470‐2045(23)00148‐1 – ident: e_1_2_9_196_1 doi: 10.21037/tau.2019.09.38 – ident: e_1_2_9_85_1 doi: 10.1016/j.jsxm.2016.05.005 – ident: e_1_2_9_99_1 doi: 10.1038/s41571‐019‐0218‐0 – volume-title: NCCN Clinical Practice Guidelines in Oncology. Kidney Cancer Version 2.2025 year: 2024 ident: e_1_2_9_98_1 – ident: e_1_2_9_70_1 doi: 10.1001/jamaoncol.2019.4489 – volume-title: Complete Prevalence (ComPrev) Software, version 3.0.31 year: 2022 ident: e_1_2_9_9_1 – ident: e_1_2_9_27_1 doi: 10.1159/000516114 – ident: e_1_2_9_165_1 doi: 10.1038/s41391‐024‐00815‐1 – ident: e_1_2_9_182_1 doi: 10.1200/op.23.00747 – ident: e_1_2_9_135_1 doi: 10.3390/curroncol29030150 – ident: e_1_2_9_137_1 doi: 10.1016/j.jtho.2021.02.024 – ident: e_1_2_9_192_1 doi: 10.21037/tau‐23‐124 – ident: e_1_2_9_203_1 doi: 10.1016/j.ygyno.2021.02.037 – ident: e_1_2_9_195_1 doi: 10.1002/cam4.3429 – ident: e_1_2_9_51_1 doi: 10.1093/jnci/djx140 – ident: e_1_2_9_74_1 doi: 10.1001/jama.2021.0106 – ident: e_1_2_9_184_1 doi: 10.1200/jco.21.01841 – ident: e_1_2_9_128_1 doi: 10.1097/MLR.0000000000001280 – ident: e_1_2_9_140_1 doi: 10.1016/j.lungcan.2018.12.028 – ident: e_1_2_9_266_1 doi: 10.1002/pon.3118 – ident: e_1_2_9_84_1 doi: 10.1097/ncc.0000000000000785 – ident: e_1_2_9_221_1 doi: 10.1200/JCO.18.01764 – ident: e_1_2_9_263_1 doi: 10.1377/hlthaff.2017.0134 – ident: e_1_2_9_58_1 doi: 10.1200/jco.19.02242 – volume-title: NCCN Clinical Practice Guidelines in Oncology, Testicular Cancer Version 2.2024 year: 2024 ident: e_1_2_9_174_1 – ident: e_1_2_9_144_1 doi: 10.1056/NEJMoa2402604 – ident: e_1_2_9_119_1 doi: 10.3390/cancers15133310 – ident: e_1_2_9_121_1 doi: 10.1016/j.jiac.2016.05.006 – ident: e_1_2_9_206_1 doi: 10.1016/j.ajog.2018.08.002 – ident: e_1_2_9_208_1 doi: 10.1016/j.ajog.2021.10.031 – volume-title: SEER*Explorer. Cancer Statistics Explorer Network, SEER Program year: 2024 ident: e_1_2_9_8_1 – ident: e_1_2_9_244_1 doi: 10.1177/1357633x211051677 – ident: e_1_2_9_179_1 doi: 10.1089/thy.2020.0944 – volume-title: SEER*Stat software, version 8.4.3 year: 2024 ident: e_1_2_9_20_1 – ident: e_1_2_9_163_1 doi: 10.1056/NEJMoa2022485 – ident: e_1_2_9_97_1 doi: 10.1016/j.euf.2018.09.020 – ident: e_1_2_9_65_1 doi: 10.1001/jamacardio.2016.2132 – ident: e_1_2_9_69_1 doi: 10.1200/jco.21.02538 – ident: e_1_2_9_197_1 doi: 10.1016/j.urology.2020.10.039 – ident: e_1_2_9_71_1 doi: 10.1002/onco.13870 – ident: e_1_2_9_222_1 doi: 10.1200/JCO.2013.49.3205 – ident: e_1_2_9_111_1 doi: 10.1016/S0140‐6736(19)33018‐1 – ident: e_1_2_9_57_1 doi: 10.1200/JCO.2018.78.1914 – ident: e_1_2_9_131_1 doi: 10.1016/j.jpainsymman.2022.05.016 – ident: e_1_2_9_236_1 doi: 10.1016/j.amepre.2015.08.008 – ident: e_1_2_9_204_1 doi: 10.1016/j.ajog.2020.02.041 – ident: e_1_2_9_28_1 doi: 10.1080/14737140.2020.1732213 – ident: e_1_2_9_267_1 doi: 10.1093/jnci/djab192 – ident: e_1_2_9_15_1 doi: 10.1002/cncr.20910 – ident: e_1_2_9_79_1 doi: 10.1200/jco.23.00539 – ident: e_1_2_9_33_1 doi: 10.1245/s10434‐016‐5443‐5 – ident: e_1_2_9_136_1 doi: 10.3389/fimmu.2023.1138483 – ident: e_1_2_9_39_1 doi: 10.1001/jama.2023.25881 – ident: e_1_2_9_176_1 doi: 10.1001/jama.2024.27122 – ident: e_1_2_9_171_1 doi: 10.1001/jamaoncol.2024.1549 – ident: e_1_2_9_260_1 doi: 10.1007/s11764‐022‐01268‐y – ident: e_1_2_9_32_1 doi: 10.1007/s10549‐013‐2745‐1 – ident: e_1_2_9_107_1 doi: 10.1002/ajh.27443 – ident: e_1_2_9_271_1 doi: 10.1158/1055‐9965.Epi‐24‐1750 – ident: e_1_2_9_239_1 doi: 10.6004/jnccn.2023.7114 – ident: e_1_2_9_125_1 doi: 10.1182/blood.2024024166 – ident: e_1_2_9_226_1 doi: 10.1007/s11764‐017‐0660‐x – ident: e_1_2_9_259_1 doi: 10.1370/afm.2498 – volume: 21 start-page: 145 issue: 4 year: 2019 ident: e_1_2_9_188_1 article-title: Intravesical therapy for non‐muscle invasive bladder cancer—current and future options in the age of bacillus Calmette–Guerin shortage publication-title: Rev Urol – ident: e_1_2_9_256_1 doi: 10.1056/NEJMsb1305469 – ident: e_1_2_9_4_1 doi: 10.1093/jncics/pkaa123 – ident: e_1_2_9_241_1 doi: 10.1007/s10549‐020‐05644‐z – ident: e_1_2_9_169_1 doi: 10.1002/phar.2168 – ident: e_1_2_9_25_1 doi: 10.1093/bjsopen/zrae040 – ident: e_1_2_9_161_1 doi: 10.1056/NEJMoa2107322 – ident: e_1_2_9_224_1 doi: 10.1053/j.seminoncol.2020.02.007 – ident: e_1_2_9_183_1 doi: 10.1016/j.ctrv.2015.09.001 – ident: e_1_2_9_93_1 doi: 10.1001/jama.2024.12848 – ident: e_1_2_9_216_1 doi: 10.1002/cncr.32675 – ident: e_1_2_9_194_1 doi: 10.1158/1055‐9965.Epi‐18‐1280 – ident: e_1_2_9_261_1 doi: 10.3322/caac.21719 – ident: e_1_2_9_116_1 doi: 10.1002/cam4.1383 – ident: e_1_2_9_141_1 doi: 10.1016/j.jtho.2020.09.011 – ident: e_1_2_9_34_1 doi: 10.1056/NEJMoa1910549 – ident: e_1_2_9_16_1 doi: 10.1016/S1470‐2045(17)30186‐9 – ident: e_1_2_9_36_1 doi: 10.1056/NEJMoa2028485 – ident: e_1_2_9_6_1 doi: 10.1002/sim.1304 – ident: e_1_2_9_7_1 doi: 10.1093/jnci/djad205 – ident: e_1_2_9_252_1 doi: 10.1073/pnas.1617464114 – ident: e_1_2_9_100_1 doi: 10.1007/s11523‐023‐00951‐z – ident: e_1_2_9_5_1 doi: 10.1080/07347332.2018.1522411 – ident: e_1_2_9_201_1 doi: 10.5489/cuaj.221 – ident: e_1_2_9_48_1 doi: 10.1002/cncr.35515 – ident: e_1_2_9_189_1 doi: 10.1016/S0140‐6736(22)01188‐6 – volume-title: FDA approves nivolumab plus cabozantinib for advanced renal cell carcinoma year: 2021 ident: e_1_2_9_96_1 – ident: e_1_2_9_198_1 doi: 10.1016/j.sxmr.2021.10.005 – ident: e_1_2_9_108_1 doi: 10.1002/ajh.26550 – ident: e_1_2_9_254_1 doi: 10.1002/cncr.33913 – ident: e_1_2_9_170_1 doi: 10.1093/jnci/djab196 – ident: e_1_2_9_112_1 doi: 10.1016/S0140‐6736(12)62187‐4 – ident: e_1_2_9_68_1 doi: 10.1200/JOP.2016.017210 – ident: e_1_2_9_10_1 doi: 10.1007/978-0-387-88441-7 – volume-title: FDA approves lenvatinib plus pembrolizumab for advanced renal cell carcinoma year: 2021 ident: e_1_2_9_95_1 – ident: e_1_2_9_91_1 doi: 10.1016/j.eururo.2011.06.049 – ident: e_1_2_9_160_1 doi: 10.1056/NEJMoa1704174 – ident: e_1_2_9_233_1 doi: 10.1001/jamaoncol.2023.4952 – ident: e_1_2_9_26_1 doi: 10.6004/jnccn.2018.0012 – ident: e_1_2_9_72_1 doi: 10.1200/PO.21.00245 – ident: e_1_2_9_253_1 doi: 10.1001/jamaoncol.2023.2144 – ident: e_1_2_9_180_1 doi: 10.1089/thy.2014.0335 – ident: e_1_2_9_228_1 doi: 10.1016/S1470‐2045(13)70251‐1 – volume-title: SEER Cancer Statistics Review 1975–2018 year: 2021 ident: e_1_2_9_23_1 – ident: e_1_2_9_55_1 doi: 10.1016/S1470‐2045(20)30666‐5 – ident: e_1_2_9_234_1 doi: 10.1200/JCO.19.00382 – ident: e_1_2_9_13_1 doi: 10.1245/s10434‐019‐07213‐1 – ident: e_1_2_9_83_1 doi: 10.1002/pon.5657 – ident: e_1_2_9_149_1 doi: 10.1056/NEJMra1703481 – ident: e_1_2_9_227_1 doi: 10.1089/jayao.2017.0089 – ident: e_1_2_9_248_1 doi: 10.1001/jama.2019.7657 – ident: e_1_2_9_250_1 doi: 10.1200/jco.22.01951 – ident: e_1_2_9_117_1 doi: 10.1002/ajh.27470 – ident: e_1_2_9_178_1 doi: 10.1089/thy.2015.0020 – ident: e_1_2_9_139_1 doi: 10.7326/M21‐0252 – ident: e_1_2_9_60_1 doi: 10.1007/s10549‐017‐4555‐3 – ident: e_1_2_9_113_1 doi: 10.1093/jnci/djv439 – ident: e_1_2_9_215_1 doi: 10.1200/JCO.2008.19.8150 – ident: e_1_2_9_73_1 doi: 10.1200/JCO.2018.36.15_suppl.3594 – ident: e_1_2_9_29_1 doi: 10.1016/j.jss.2020.12.057 – ident: e_1_2_9_110_1 doi: 10.1093/jnci/djab184 – ident: e_1_2_9_53_1 doi: 10.1200/JCO.2017.75.8995 – ident: e_1_2_9_78_1 doi: 10.1371/journal.pmed.1003842 – ident: e_1_2_9_138_1 doi: 10.1136/thoraxjnl‐2018‐212456 – ident: e_1_2_9_133_1 doi: 10.1177/23743735221077524 – ident: e_1_2_9_185_1 doi: 10.1038/s41598‐022‐07592‐8 – ident: e_1_2_9_92_1 doi: 10.1093/annonc/mdz056 – ident: e_1_2_9_56_1 doi: 10.1200/edbk_390442 – ident: e_1_2_9_94_1 doi: 10.1200/edbk_280817 – ident: e_1_2_9_237_1 doi: 10.1007/s10549‐006‐9479‐2 – volume-title: International Classification of Diseases for Oncology year: 2000 ident: e_1_2_9_14_1 – ident: e_1_2_9_66_1 doi: 10.1200/JCO.2016.70.5400 – ident: e_1_2_9_143_1 doi: 10.1016/S0140‐6736(23)00821‐8 – volume-title: SEER*Stat Database: Incidence year: 2024 ident: e_1_2_9_18_1 – ident: e_1_2_9_162_1 doi: 10.1056/NEJMoa1911440 – volume-title: FDA grants accelerated approval to lifileucel for unresectable or metastatic melanoma year: 2024 ident: e_1_2_9_145_1 – ident: e_1_2_9_86_1 doi: 10.1007/s00520‐018‐4268‐0 – ident: e_1_2_9_148_1 doi: 10.1016/j.bjps.2019.08.011 – ident: e_1_2_9_167_1 doi: 10.1158/1055‐9965.Epi‐24‐1228 – ident: e_1_2_9_242_1 doi: 10.1200/GO.20.00423 – ident: e_1_2_9_22_1 doi: 10.1093/jnci/djac158 – ident: e_1_2_9_210_1 doi: 10.1056/NEJMoa2302312 – ident: e_1_2_9_251_1 doi: 10.1038/s41467‐020‐16970‐7 – ident: e_1_2_9_126_1 doi: 10.1056/NEJMoa2401361 – ident: e_1_2_9_88_1 doi: 10.1200/JCO.20.01330 – ident: e_1_2_9_3_1 doi: 10.1158/1055‐9965.EPI‐12‐0740 – ident: e_1_2_9_157_1 doi: 10.1001/jamanetworkopen.2021.12214 – ident: e_1_2_9_213_1 doi: 10.1200/JCO.19.00151 – ident: e_1_2_9_243_1 doi: 10.1016/j.annonc.2021.09.001 – ident: e_1_2_9_67_1 doi: 10.3322/caac.21772 – ident: e_1_2_9_191_1 doi: 10.1001/jama.2020.17598 – ident: e_1_2_9_150_1 doi: 10.18632/oncotarget.21059 – ident: e_1_2_9_186_1 doi: 10.1056/NEJMra1501993 – ident: e_1_2_9_265_1 doi: 10.1037/a0034216 – ident: e_1_2_9_44_1 doi: 10.1200/JCO.19.02896 – ident: e_1_2_9_220_1 doi: 10.1016/S1470‐2045(24)00157‐8 – ident: e_1_2_9_45_1 doi: 10.1200/JCO.21.01681 – ident: e_1_2_9_103_1 doi: 10.1038/s41408‐021‐00425‐3 – ident: e_1_2_9_164_1 doi: 10.1002/cam4.2092 – volume-title: SEER*Stat Database: Incidence year: 2023 ident: e_1_2_9_154_1 – reference: 40944902 - CA Cancer J Clin. 2025 Sep 13. doi: 10.3322/caac.70036. |
| SSID | ssj0000777 |
| Score | 2.5969586 |
| Snippet | The number of people living with a history of cancer in the United States continues to rise because of the growth and aging of the population as well as... |
| SourceID | pubmedcentral proquest pubmed crossref wiley |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 308 |
| SubjectTerms | Adult Aged Black people Cancer Survivors - statistics & numerical data Cancer therapies Epidemiology Female Humans Lung cancer Male Melanoma Middle Aged Neoplasms - epidemiology Neoplasms - mortality Neoplasms - therapy Prevalence Public health Racial differences SEER Program Statistics Survival Survivorship treatment patterns United States - epidemiology |
| Title | Cancer treatment and survivorship statistics, 2025 |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.3322%2Fcaac.70011 https://www.ncbi.nlm.nih.gov/pubmed/40445120 https://www.proquest.com/docview/3230947818 https://www.proquest.com/docview/3214314721 https://pubmed.ncbi.nlm.nih.gov/PMC12223361 |
| Volume | 75 |
| WOSCitedRecordID | wos001499809500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library customDbUrl: eissn: 1542-4863 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000777 issn: 0007-9235 databaseCode: WIN dateStart: 19970101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell – providerCode: PRVWIB databaseName: Wiley Online Library Open Access customDbUrl: eissn: 1542-4863 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000777 issn: 0007-9235 databaseCode: 24P dateStart: 19970101 isFulltext: true titleUrlDefault: https://authorservices.wiley.com/open-science/open-access/browse-journals.html providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS_QwFL2Iirjx_agvKrpRLLbpIym4GQbFDz4HF4qzK0maoCAdmXH8_d6bdqqDIoibUOhNGnLyOLe5OQE4Fia0FnltYLkU6KBIRkEAJAggS8GszpRxSP_nvZ7o9_PbGbiYnIWp9SHaH240Mtx8TQNcKncLSYx9EEHUEj9Iu6bo-8xFUSzo4gaW3H7Mw5zXipkhD5DGpLU4KeU-_8g7vRx94ZhfQyU_U1i3Bl0t_632K7DUcE-_U3eWVZgx1Ros3DS762uwSMyzFm5eB9al_jD020h0X1alPxrj1PI2cLHP_qg1P_MZspoNuL-6vOteB80FC4EmWbJApjZDhqHSVCZ5qYROrFQiVWFZxiYOVcYSbksjkTNpra2SLOO5lRnCmphMingTZqtBZbbBtyaLdInFpkYkeaxUyjiyHSFyToFUyoOTSTsXulEfp0swngv0QqhNCmqRwrWIB0et7UutufGt1d4ErqIZd6MiRo8qp9OzwoPD9jWOGNoGkZUZjMkGOWKUoOvrwVaNbvuZJCTBNhZ6IKZwbw1IjXv6TfX06FS5I2JacYaFnjrgf6h60e10uu5p5zfGu7BIYNbhh3sw-zocm32Y12-I9fDAdX5MeV9g-vCv9w6MqQeg |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8QwEB5ERb34WF_1WdGLYrHbV9Ljsigu7i4eFL2VJE1QkK7suv5-Z9LadVEE8VbINC3zZdJvkukXgBOufWOQ13qGCY4JigioCIAEAUTOA6MSqS3SXdbv88fH9LaqzaF_YUp9iHrBjSLDztcU4LQgTVEe4iBEFJXAJ9K2KSY_cxEyDTq54aHTn0zEjJWSmT7zkMfEpTop3X0xuXf6e_SNZH6vlfzKYe1H6Grln6-_CssV-3Rb5XBZgxldNGChV-2vN2CJuGcp3bwOQZtGxNCta9FdUeTuaIyTy_vAVj-7o9r83A2Q12zA_dXlXfvaq45Y8BQJk3kiNglyDBnHIkpzyVVkhOSx9PM81KEvkyBiJtcCWZNSykgRJCw1IkFgI50IHm7CbDEo9Da4RidNlWO3seZRGkoZBwz5Ducpo1Iq6cDpp6MzVemP0zEYLxnmIeSTjDySWY84cFzbvpaqGz9a7X3ilVWRN8pCzKlS-n-WO3BUN2PM0EaIKPRgTDbIEpsRJr8ObJXw1o-JfJJsC3wH-BTwtQHpcU-3FM9PVpe7SVwrTLDTM4v8L6-etVuttr3a-YvxISxe3_W6WbfTv9mFJQK2LEbcg9m34Vjvw7x6R9yHBzYSPgB7hgoB |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Ra9swED5KW0pf2i3bOq_p6rK9bMzUkWVLfgxpQ8fSkIcN-mYkWWKD4YSkye_fnew4DRmDsjeDzpLQp5O-s86fAD5KGzuHvDZyQkkMUBSjJAASBFClZM5k2nqkR2I8lg8P-aTJzaF_YWp9iPaDG3mGX6_Jwe2sdOTlCU5CRNEobJGOTTH4OeCp6NGkZnyyWYiFqCUzYxEhj0lrdVJ6-3rz7vZ-tEMyd3Mln3JYvwkNT_-z-y_gpGGfYb-eLi9hz1YdOLpvztc7cEzcs5ZufgVsQDNiHra56KGqynCxxMVlNfXZz-GiNf8SMuQ1r-HH8Pb74C5qrliIDAmTRSp1GXIMnaaK56WWhjulZarjskxsEuuMceFKq5A1GWOcViwTuVMZAsttpmTyBvaraWXfQuhs1jMlVptayfNE65QJ5DtS5oJSqXQAn9YDXZhGf5yuwfhdYBxCY1LQiBR-RAL40NrOatWNv1p113gVjectigRjqpz-n5UBXLXF6DN0EKIqO12SDbLEHsfgN4CzGt62GR6TZBuLA5BbwLcGpMe9XVL9-ul1uXvEtZIMK_3skf9H14tBvz_wT--eY3wJR5ObYTH6Ov52DseEa52L2IX9x_nSXsChWSHs8_feEf4AcpQJGA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cancer+treatment+and+survivorship+statistics%2C+2025&rft.jtitle=CA%3A+a+cancer+journal+for+clinicians&rft.au=Wagle%2C+Nikita+Sandeep&rft.au=Nogueira%2C+Leticia&rft.au=Devasia%2C+Theresa+P&rft.au=Mariotto%2C+Angela+B&rft.date=2025-08-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=0007-9235&rft.eissn=1542-4863&rft.volume=75&rft.issue=4&rft.spage=308&rft_id=info:doi/10.3322%2Fcaac.70011&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-9235&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-9235&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-9235&client=summon |